col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: American Society of Hematology

588 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Blood 2022―Aug―04 CLL and COVID-19: light at the end of the tunnel? Lydia Scarfò, Yair Herishanu
2 [GO] Blood 2022―Jul―15 Clonal Hematopoiesis Is Not Significantly Associated with Covid-19 Disease Severity Yifan Zhou, Ruba N Shalhoub, Stephanie N Rogers, Shiqin Yu, Muxin Gu, Margarete Alice Fabre, et al. (+37)
3 [GO] Blood 2022―Jul―14 Buckling up against COVID-19 after CAR T-cell therapy Jeffery J. Auletta
4 [GO] Blood Advances 2022―Jul―05 Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19 Cédric Garcia, Jonathan Au Duong, Michael Poëtte, Agnès Ribes, Bruno Payre, Vincent Mémier, et al. (+5)
5 [GO] Blood 2022―Jul―01 How I Treat and Prevent COVID-19 in Patients with Hematologic Malignancies and Recipients of Cellular Therapies Firas El Chaer, Jeffery J Auletta, Roy F Chemaly
6 [GO] Blood Advances 2022―Jun―29 Emerging Clinical Trial Designs May Accelerate Translation in Hematology: Lessons from COVID-19 Matthew D Neal, Patrick R Lawler, Ryan Zarychanski
7 [GO] Blood Advances 2022―Jun―27 COVID-19 and venous thromboembolism risk in patients with sickle cell disease Ashima Singh, Amanda M. Brandow, Ted Wun, Arun S. Shet
8 [GO] The Hematologist 2022―Jun―23 Heparin-Induced Thrombocytopenia in COVID-19 Surbhi Shah, Alma Habib
9 [GO] Blood 2022―Jun―03 Introduction to a Review Series on COVID-19 Thomas L. Ortel, Nancy Berliner
10 [GO] Blood 2022―Jun―02 Anticoagulation in Hospitalized Patients with COVID-19 Lisa Baumann Kreuziger, Michelle Sholzberg, Mary Cushman
11 [GO] Blood Advances 2022―Jun―02 Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination Agnes Y. Y. Lee, Muntadhar Al Moosawi, Erica A. Peterson, Rita K. McCracken, Steven K. W. Wong, Hamish Nicolson, et al. (+23)
12 [GO] Blood 2022―May―23 Increased COVID-19 Breakthrough Infection Risk in Patients with Plasma Cell Disorders Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Linden Huhmann, Summer S Han, Mary T. Brophy, et al. (+4)
13 [GO] Blood 2022―May―19 Patients with CLL have lower risk of death from COVID-19 in the omicron era Carsten Utoft Niemann, Caspar da Cunha-Bang, Marie Helleberg, Sisse R Ostrowski, Christian Brieghel
14 [GO] Blood 2022―May―11 COVID-19 in patients with hematologic malignancy Petra Langerbeins, Michael Hallek
15 [GO] Blood 2022―May―10 Vaccine-induced T cells against Sars-Cov-2 and its Omicron variant in B cell-depleted lymphoma patients after CART Djordje Atanackovic, Tim Luetkens, Destiny Omili, Thierry Iraguha, Forat Lutfi, Nancy M Hardy, et al. (+17)
16 [GO] Blood Advances 2022―May―04 Aiello S, Gastoldi S, Galbusera M, et al. C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19. Blood Adv. 2022;6(3):866-881.
17 [GO] Blood Advances 2022―May―03 American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+40)
18 [GO] Blood Advances 2022―May―02 COVID-19 and Hairy-Cell Leukemia: An EPICOVIDEHA Survey Sylvain Lamure, Jon Salmanton-García, Elena ROBIN MARIETON, Ozren Jaksic, Milena Kohn, Francesco Marchesi, et al. (+40)
19 [GO] Blood 2022―Apr―30 Thrombocytopenia and splenic platelet directed immune responses after intravenous ChAdOx1 nCov-19 administration Leo Nicolai, Alexander Leunig, Kami Pekayvaz, Max Esefeld, Afra Anjum, Justina Rath, et al. (+19)
20 [GO] The Hematologist 2022―Apr―25 A GPS for Those Lost in the Pandemic: Apollo's Arrow by Nicholas Christakis Parameswaran Hari
21 [GO] Blood 2022―Apr―22 Clinical features of thrombosis and bleeding in COVID-19 Mari Thomas, Marie Scully
22 [GO] Blood Advances 2022―Apr―22 SARS-CoV-2 Infection Associated with Aplastic Anemia and Pure Red Cell Aplasia Nicholas C Lee, Bhavisha A Patel, Aaron M. Etra, Taha Bat, Ibrahim F Ibrahim, Madhuri Vusirikala, et al. (+5)
23 [GO] Blood 2022―Apr―21 De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring Guillaume Moulis, Etienne Crickx, Laure Thomas, Nathalie Massy, Matthieu Mahévas, Marie-Blanche Valnet-Rabier, et al. (+5)
24 [GO] Blood Advances 2022―Apr―20 Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells Florian Puhm, Isabelle Allaeys, Emile Lacasse, Isabelle Dubuc, Yannick Galipeau, Younes Zaid, et al. (+8)
25 [GO] Blood Advances 2022―Apr―20 Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern Maggie Li, Evan J Beck, Oliver Laeyendecker, Yolanda Eby, Aaron AR Tobian, Patrizio Caturegli, et al. (+28)
26 [GO] Blood Advances 2022―Apr―19 Singh A, Brandow AM, Panepinto JA. COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals. Blood Adv. 2021;5(7):1915-1921.
27 [GO] Blood Advances 2022―Apr―14 Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19 Eugenio Damaceno Hottz, Remy Martins-Gonçalves, Lohanna Palhinha, Isaclaudia G. Azevedo-Quintanilha, Mariana M. de Campos, Carolina Q. Sacramento, et al. (+13)
28 [GO] Blood 2022―Mar―28 Neutralization of SARS-CoV-2 Omicron after vaccination of myelodysplastic syndromes and acute myeloid leukemia patients Lorenza Bellusci, Gabrielle Grubbs, Pragya Srivastava, Michael J Nemeth, Elizabeth A Griffiths, Hana Golding, Surender Khurana
29 [GO] Blood Advances 2022―Mar―14 Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity Sigrun Einarsdottir, Anna Martner, Jesper Waldenström, Malin Nicklasson, Johan Ringlander, Mohammad Arabpour, et al. (+14)
30 [GO] Blood 2022―Mar―10 Danger ahead: COVID-19 infections after vaccination Lee M. Greenberger, Gwen L. Nichols
31 [GO] Blood 2022―Mar―10 Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination Adrien Picod, Jean-Michel Rebibou, Antoine Dossier, Bérengère Cador, David Ribes, Claire Vasco-Moynet, et al. (+12)
32 [GO] Blood 2022―Mar―09 Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose Katarzyna Krzywicka, Anita van de Munckhof, Julian Zimmerman, Felix J. Bode, Giovanni Frisullo, Theodoros Karapanayiotides, et al. (+8)
33 [GO] Blood 2022―Mar―08 SARS-CoV-2 Vaccination and Immune Thrombotic Thrombocytopenic Purpura Hridaya Shah, Ann Soo Kim, Senthil Sukumar, Marshall A. Mazepa, Ruhail Kohli, Evan M. Braunstein, et al. (+3)
34 [GO] Blood Advances 2022―Mar―04 Commissioned Commentary on the 2021 American Society of Hematology Guidelines on use of anticoagulation in patients with COVID-19 being discharged from the hospital Alex C. Spyropoulos, Renato D. Lopes
35 [GO] Blood 2022―Mar―03 Cellular therapies for the treatment and prevention of SARS-CoV-2 infection Susan Conway, Michael D. Keller, Catherine M. Bollard
36 [GO] Blood Advances 2022―Mar―02 Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19 Michael W. Henderson, Franciele Lima, Carla Roberta Peachizepi Moraes, Anton Ilich, Stephany Cares Huber, Mayck Silva Barbosa, et al. (+16)
37 [GO] Blood Advances 2022―Feb―03 Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients Sabine Haggenburg, Birgit I. Lissenberg-Witte, Rob S Van BInnendijk, Gerco Den Hartog, Michel S Bhoekhan, Nienke J.E. Haverkate, et al. (+41)
38 [GO] Blood Advances 2022―Feb―02 Antibody response to mRNA vaccination for COVID-19 in patients with AML receiving hypomethylating agents alone or with venetoclax ANNA CANDONI
39 [GO] Blood Advances 2022―Jan―24 A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses Elena Pettini, Annalisa Ciabattini, Gabiria Pastore, Jacopo Polvere, Simone Lucchesi, Fabio Fiorino, et al. (+5)
40 [GO] Blood Advances 2022―Jan―24 Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study J. Erika Haydu, Jenny S Maron, Robert A Redd, Kathleen M E Gallagher, Stephanie Fischinger, Jeffrey A. Barnes, et al. (+24)
41 [GO] Blood Advances 2022―Jan―10 Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19 Jan Zlamal, Karina Althaus, Hisham Jaffal, Helene Häberle, Lisann Pelzl, Anurag Singh, et al. (+10)
42 [GO] Blood Advances 2022―Jan―10 Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity Hoda Pourhassan, CORINNA LA ROSA, Flavia Chiuppesi, Alfredo Puing, Ibrahim Aldoss, Yoonsuh Park, et al. (+12)
43 [GO] Blood Advances 2022―Jan―10 SARS-CoV-2-specific T-cell responses to recurrent COVID-19 pneumonitis in a patient with post-CART B cell aplasia Angus Hodder, Lindsey Williams, Jan Chu, Alasdair Bamford, Charlene Rodrigues, Kimberley C Gilmour, et al. (+5)
44 [GO] The Hematologist 2022―Jan―10 Anticoagulants for Hospitalized Patients With COVID-19: The Year of Randomized Controlled Trials Damon Houghton
45 [GO] The Hematologist 2022―Jan―10 Chronic Lymphocytic Leukemia and a Pandemic: A Bad Combination Brad Kahl
46 [GO] Blood Advances 2022―Jan―06 Inflammasome activation in neutrophils of patients with severe COVID-19 Karen Aymonnier, Julie Ng, Laura E Fredenburgh, Katherin Zambrano-Vera, Patrick Münzer, Sarah Gutch, et al. (+8)
47 [GO] Blood 2022―Jan―05 Vasculopathy in COVID-19 Robert Flaumenhaft, Keiichi Enjyoji, Alec A Schmaier
48 [GO] Blood 2022―Jan―05 Booster BNT162b2 Optimizes SARS-CoV-2 Humoral Response in Myeloma Patients; the Negative Effect of anti-BCMA therapy Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, et al. (+6)
49 [GO] Blood Advances 2021―Dec―24 COVID-19 vaccination in patients with immune thrombocytopenia Chantal Visser, Maurice Swinkels, Erik van Werkhoven, F. Nanne Nanne Croles, Heike Susanne Noordzij-Nooteboom, Matthijs Eefting, et al. (+12)
50 [GO] Blood Advances 2021―Dec―23 Impaired Immune Response to COVID-19 Vaccination in Patients with B-Cell Malignancies after CD19 CART Cell Therapy Saurabh Dahiya, Tim Luetkens, Forat Lutfi, Stephanie V. Avila, Thierry Iraguha, Philip J Margiotta, et al. (+10)
51 [GO] Blood Advances 2021―Dec―15 SARS-CoV-2 neutralizing antibody treatment in COVID-19 patients with immunodeficiency due to B-cell non-Hodgkin lymphoma Jakob J Malin, Veronica Di Cristanziano, Carola Horn, Elisabeth Pracht, Jorge Garcia Borrega, Eva Heger, et al. (+10)
52 [GO] Blood Advances 2021―Dec―14 Booster effect after SARS-CoV-2 vaccination in hematological immunocompromised patients with prior COVID-19 Jose Luis L Piñana, Ramon Garcia-Sanz, RODRIGO MARTINO, Maria Garcia-Roa, Gabriel-Andres Martin-Martin, Irene Risco-Galvez, et al. (+11)
53 [GO] Blood 2021―Dec―14 Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against Alpha and Delta variants in Multiple Myeloma patients Soledad Henriquez, Jérémie Zerbit, Timothée Bruel, Amani Ouedrani, Delphine Planas, Paul Deschamps, et al. (+15)
54 [GO] Hematology 2021―Dec―10 Passive immune therapies: another tool against COVID-19 Lise J. Estcourt
55 [GO] Hematology 2021―Dec―10 COVID-19 and thrombosis: searching for evidence Bright Thilagar, Mohammad Beidoun, Ruben Rhoades, Scott Kaatz
56 [GO] Hematology 2021―Dec―10 MPN and thrombosis was hard enough . . . now there's COVID-19 thrombosis too Anna Falanga
57 [GO] Hematology 2021―Dec―10 How to recognize and manage COVID-19-associated coagulopathy Gloria F. Gerber, Shruti Chaturvedi
58 [GO] Blood Advances 2021―Dec―06 Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia Zoe Lyski, Myung S Kim, David Xthona Lee, Hans-Peter Raué , Vikram Raghunathan, Janet Griffin, et al. (+6)
59 [GO] Blood Advances 2021―Dec―03 Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19 Malgorzata Wygrecka, Anna Birnhuber, Benjamin Seeliger, Laura Michalick, Oleg Pak, Astrid-Solveig Schultz, et al. (+19)
60 [GO] Blood 2021―Dec―03 Efficacy of a Third BNT162b2 mRNA COVID-19 Vaccine Dose in Patients with CLL who Failed Standard Two-dose Vaccination Yair Herishanu, Galia Rahav, Shai Levi, Andrei Braester, Gilad Itchaki, Osnat Bairey, et al. (+6)
61 [GO] Blood Advances 2021―Dec―01 C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19 Sistiana Aiello, Sara Gastoldi, Miriam Galbusera, Piero Luigi Ruggenenti, Valentina Portalupi, Stefano Rota, et al. (+9)
62 [GO] Blood Advances 2021―Dec―01 Immunogenicity of COVID-19 vaccines in patients with hematological malignancy: a systematic review and meta-analysis Joanne S.K. Teh, Julien Coussement, Zoe C.F. Neoh, Tim Spelman, Smaro Lazarakis, Monica A Slavin, Benjamin W Teh
63 [GO] Blood Advances 2021―Nov―29 Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies Moraima Jiménez, Elisa Roldan, Candela Fernández- Naval, Guillermo Villacampa, Monica Martinez-Gallo, Daniel Medina-Gil, et al. (+23)
64 [GO] Blood 2021―Nov―25 Concurrent COVID-19 and babesiosis in an older, splenectomized patient Jeremy W. Jacobs, Alexa J. Siddon
65 [GO] Blood 2021―Nov―24 The Correlation between Racial/Ethnic Groups, Thrombosis, and Mortality in Hospitalized Patients with COVID-19 Maya Rodriguez, Wen Dai, Hayley Lund, Kristen Osinski, Ziyu Zhang, Silvia Munoz-Price, et al. (+2)
66 [GO] Blood 2021―Nov―24 Circulating Levels of Ang/Tie2 and VEGF-a Pathway Mediators Are Associated with Clinical Severity, Endothelial Barrier Disruption and Coagulation Activation in COVID-19 Carla Roberta Peachazepi de Moraes, Ivanio Teixeira de Borba Junior, Franciele de Lima, Mayck Silva Barbosa, Stephany Cares Huber, Andre C. Palma, et al. (+13)
67 [GO] Blood 2021―Nov―24 High Plasma Apolipoprotein(a) Concentration and Low Plasmin Tpa Enzymatic Activity in Hospitalized Patients with COVID-19 Ziyu Zhang, Wen Dai, Wen Zhu, Maya Rodriguez, Mary Rau, Hayley Lund, et al. (+4)
68 [GO] Blood 2021―Nov―24 The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19 Patrick Van Dreden, Douglas D Fraser, Guillaume Voiriot, Aurélie Rousseau, Ismail Elalamy, Ioannis Prassas, et al. (+4)
69 [GO] Blood 2021―Nov―24 A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies Susanne Ghandili, Christian Niederwieser, Katja Weisel, Carsten Bokemeyer, Walter Fiedler, Franziska Modemann
70 [GO] Blood 2021―Nov―24 Comparison of Thrombotic Complications in Critically Ill Patients between COVID-19 and Mers-COV Abdulrahman Al Raizah, Khalid Aldosari, Mohamed Alnahdi, Naila Shaheen, Mosaad Almegren, Mohammed Al Shuaibi, Turki Alshuaibi
71 [GO] Blood 2021―Nov―24 Humoral Immunity and Adverse Events after Vaccination Against COVID-19 By a Vector Based Vaccine Sputnik V in Patients with Chronic Myeloid Leukemia Ekaterina Yu. Chelysheva, Anna Petrova, Oleg A. Shukhov, Margarita Gurianova, Anastasiya Bykova, Irina Nemchenko, et al. (+3)
72 [GO] Blood 2021―Nov―24 Evaluation of the Relationship between Clonal Hematopoiesis and Severe COVID-19 Disease in Rhesus Macaques Taehoon Shin, Yifan Zhou, So Gun Hong, John-Paul Todd, Shayne Andrew, Barbara Flynn, et al. (+9)
73 [GO] Blood 2021―Nov―24 COVID-19 in Children Following Hematopoietic Cell Transplantation: A Multinational Study of the European Bone Marrow Transplantation Society (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) Diana Averbuch, Rafael De La Camara, Selim Corbacioglu, Malgorzata Mikulska, Jose Luis Piñana Sanchez, Gloria Tridello, et al. (+15)
74 [GO] Blood 2021―Nov―24 COVID-19 in Hospitalized Patients with Sickle Cell Disease Stephanie Guarino, Sophie M. Lanzkron
75 [GO] Blood 2021―Nov―24 COVID-19 in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): An Observational Retrospective Study Nicola Sgherza, Paola Curci, Rita Rizzi, Silvio Tafuri, Pasquale Stefanizzi, Vanda Strafella, et al. (+7)
76 [GO] Blood 2021―Nov―24 Second Versus First Wave of COVID-19 in Patients with MPN Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli, et al. (+48)
77 [GO] Blood 2021―Nov―24 COVID-19 in Pediatric Hematopoietic Cell Transplant Recipients: A CIBMTR Study Neel S. Bhatt, Akshay Sharma, Andrew St. Martin, Michael Martens, Marcie L. Riches, Christopher E Dandoy, Jeffery J. Auletta
78 [GO] Blood 2021―Nov―24 ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report Sabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, Mario Annunziata, Anna Candoni, Cerrano Marco, et al. (+32)
79 [GO] Blood 2021―Nov―24 Neither COVID-19, Nor Cryopreservation, Prevented Allogeneic Product Infusion: A Report from the National Marrow Donor Program Heather E. Stefanski, Jeni Newman, Jennifer Novakovich, Jacklyn Barten, Jason Oakes, Meghann Cody, et al. (+4)
80 [GO] Blood 2021―Nov―24 COVID-19 Outcomes Among Participants in the NHLBI Myelodysplastic Syndromes (MDS) Natural History Study Eric Padron, Donnie Hebert, Steven D. Gore, Nancy Gillis, Rami S. Komrokji, Wael Saber, et al. (+11)
81 [GO] Blood 2021―Nov―24 Platform Incorporating Patient Navigation, Preparative Guidelines, and Hospital at Home May Improve COVID-19 Outcomes for Patients with Myeloid Malignancies Brittany Knick Ragon, Tamara K. Moyo, Ashley Sumrall, Ifeyinwa (IFY) Osunkwo, Kris Blackley, Laura Kabrich, et al. (+20)
82 [GO] Blood 2021―Nov―24 Nursing Management of Frail Patients with Hematologic Malignancies during COVID-19 Pandemia in the Viterbo Domiciliary Care Unit: Data Analysis from March 2020 to March 2021 Silvia Ciambella, Vincenza Innocenti, Elisa Emanueli Cippitelli, Silvia Bertelli, Roberta Talucci, Valentina Panichi, et al. (+14)
83 [GO] Blood 2021―Nov―24 Association of Race, Ethnicity, Age and Socioeconomic Status with Access to Virtual Visits within the Brigham & Women's Hospital Division of Hematology during the COVID-19 Pandemic Miriam Kwarteng-Siaw, Lauren E. Merz, Siyang Ren, Donna S. Neuberg, Maureen Achebe, Jorge A. Rodriguez, Arielle L. Langer
84 [GO] Blood 2021―Nov―24 Clinical Characteristics and Outcomes of Patients with Newly Diagnosed De Novo Acute Myeloid Leukemia (AML) during the COVID-19 Pandemic Hari S. Raman, Yael Flamand, Marlise R. Luskin, Daniel J. DeAngelo, Richard M. Stone, Jacqueline S. Garcia, et al. (+6)
85 [GO] Blood 2021―Nov―24 Pediatric Sickle Cell Disease and the COVID-19 Pandemic: A Year in Review at Children's National Hospital Olufunke Y. Martin, Deepika S. Darbari, Stefanie Margulies, Robert Sheppard Nickel, Alexis Leonard, Barbara Speller-Brown, et al. (+5)
86 [GO] Blood 2021―Nov―24 Possible Divergent Local and Peripheral Immunological Effects of Low-Dose Mesencure, an Enhanced Mesenchymal Cell Therapy, May Contribute to Its Success in Treating Severe Covid-19 Patients Tomer Bronshtein, Dror Ben David, Atara Novak, Vered Kivity, Shai Meretzki, Tony Hayek, et al. (+2)
87 [GO] Blood 2021―Nov―24 Characteristics and Outcomes of COVID-19 Patients with Mature B-Cell Non-Hodgkin Lymphomas (mB-Cell NHL): A US Nationwide Electronic Health Record (EHR) Database Study Xiaomeng Yue, David Hallett, Yangyang Liu, Reethi Iyengar, Elisa Basa, Huiying Yang
88 [GO] Blood 2021―Nov―24 Risk Stratification for Acute Arterial and Venous Thromboembolism using CHA 2DS 2-VASc Score in Hospitalized COVID-19 Patients: A Multicenter Study Yi Lee, Qasim Jehangir, Pin Li, Chun-Hui Lin, Anupam A Sule, Geetha Krishnamoorthy, et al. (+6)
89 [GO] Blood 2021―Nov―24 Clonal Hematopoiesis of Indeterminate Potential Is Associated with Increased Age-Independent Morbidity and Mortality in Patients with COVID-19- the Beyond DNA COVID-19 Project Marissa Li, Terra Lasho, Moritz Binder, Wazim Mohammed Ismail, Susan M. Geyer, Jenna Fernandez, et al. (+6)
90 [GO] Blood 2021―Nov―24 Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology Lisa K. Hicks, Robert A. Redd, Kenneth C. Anderson, Pinkal Desai, Brendan Dolan, Aaron D Goldberg, et al. (+10)
91 [GO] Blood 2021―Nov―24 Clinical Outcomes in Critically-Ill Patients with COVID-19 Treated with Therapeutic Dose of Anticoagulants for Suspected Thromboembolism Phyu Thin Naing, Hadya Elshakh, Lauren Elreda, Joon Ha Woo, Michael Karass, John Prudenti, Alan Wu
92 [GO] Blood 2021―Nov―24 Incidence and Predictors of Sars-Cov-2 Antibody Responses Following COVID-19 Vaccination in Allogeneic Stem Cell Transplant Recipients Janna C. Minehart, Christopher Catania, Linda Perry, Mary Ellen Martin, Jacqueline Smith, Shannon R. McCurdy, et al. (+9)
93 [GO] Blood 2021―Nov―24 Antibody and T-Cell Responses to COVID-19 Vaccination in Myeloproliferative Neoplasm Patients Joan How, Kathleen M.E. Gallagher, Yiwen Liu, Ashley DeMato, Katelin Katsis, Rebecca Larson, et al. (+4)
94 [GO] Blood 2021―Nov―24 Do Splenectomized Immune Thrombocytopenia (ITP) Patients Have Increased Risks for Platelet Decreases Following COVID-19 Vaccination? Jennifer MacWhirter - DiRaimo, Caroline Kruse, James B Bussel, Alexandra Kruse
95 [GO] Blood 2021―Nov―24 Response to COVID-19 Vaccines in Patients Receiving Intensified Post-ASCT Therapy with Daratumumab, Lenalidomide, Bortezomib (Dara-VR) Due to Ultra-High Risk (UHiR) Newly Diagnosed Myeloma (NDMM) or Primary Plasma Cell Leukemia (pPCL): Exploratory Analysis of the UK Optimum/Muknine Trial Matthew W Jenner, Andrew Hall, Sian E Faustini, Alexandra Pitchford, Ruth M. de Tute, Sadie Roberts, et al. (+12)
96 [GO] Blood 2021―Nov―24 Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib? Giovanni Caocci, Olga Mulas, Daniela Mantovani, Alessandro Costa, Andrea Galizia, Luca Barabino, et al. (+3)
97 [GO] Blood 2021―Nov―24 Implementation and Preliminary Effectiveness of mHealth Apps for Improving Sickle Cell Disease Care during COVID-19: A Mixed-Methods Evaluation Sherif M. Badawy, Lisa DiMartino, Donald Brambilla, Ana Baumann, Ebony Burns, Theresa Demartino, et al. (+7)
98 [GO] Blood 2021―Nov―24 Use of Monoclonal Antibody Therapy in Hematologic Patients with Mild-to-Moderate COVID-19: A Retrospective Single-Center Experience Idoroenyi Amanam, Janny M. Yao, Alfredo Puing, Ni-Chun Tsai, Diana Samuels, Dat Ngo, et al. (+18)
99 [GO] Blood 2021―Nov―24 Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM) Sæmundur Rögnvaldsson, Elias Eythorsson, Sigrun Thorsteinsdottir, Brynjar Vidarsson, Pall Torfi Onundarson, Bjarni Agnar Agnarsson, et al. (+22)
100 [GO] Blood 2021―Nov―24 Treatment and in-Hospital Overall Survival in Hematological Patients with Grade 4 Neutropenia and Coronavirus Infection Ksenia V. Kaluzhskaya, Yuri Yu. Polyakov, Elena A. Baryakh, Eduard G. Gemdzhian, Elena N. Misyurina, Evgenia I. Zhelnova, et al. (+7)
101 [GO] Blood 2021―Nov―24 Manufacture and Immunological Characterization of GMP-Compliant Functional Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs ® Cytokine Capture System Yaya Chu, Jordan Milner, Margaret Lamb, Elena Maryamchik, Olivia Rigot, Janet Ayello, et al. (+15)
102 [GO] Blood 2021―Nov―24 Characterization of the Humoral and Cellular Immune Response Against the Natural Infection By Sars-Cov-2 in Oncohematological Patients with Post-COVID19 Autologous Transplantation Adrián Sánchez-Tornero, Lorena Vigon, Guiomar Casado-Fernandez, Javier Garcia-Pérez, Elena Mateos, Magdalena Corona De Lapuerta, et al. (+8)
103 [GO] Blood 2021―Nov―24 Sars-Cov-2 Infection Associated with Aplastic Anemia and Pure Red Cell Aplasia Nicholas C.J. Lee, Bhavisha A. Patel, Taha Bat, Ibrahim F. Ibrahim, Madhuri Vusirikala, Mingyi Chen, et al. (+4)
104 [GO] Blood 2021―Nov―24 SARS-CoV-2 Ion Channel ORF3a Enables TMEM16F-Dependent Phosphatidylserine Externalization to Augment Procoagulant Activity of the Tenase and Prothrombinase Complexes Jacob G Ludington, Shabbir A Ansari, Alec A Schmaier, Keiichi Enjyoji, Benjamin E Nilsson-Payant, Yaron Bram, et al. (+5)
105 [GO] Blood 2021―Nov―24 Immunogenicity of Sars-Cov-2 mRNA 1273 Vaccine in Patients with Lymphoid Malignancies Ning Dong, Akriti G Jain, Elaine S Tan, Somedeb Ball, Junmin Whiting, Sameh Gaballa, et al. (+10)
106 [GO] Blood 2021―Nov―24 Antibody Response to 2-Dose Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients Alexis Maillard, Rabah Redjoul, Marion Klemencie, Hélène Labussière, Amandine Le Bourgeois, Maud d'Aveni, et al. (+10)
107 [GO] Blood 2021―Nov―24 Antibody Response after One and/or Two Doses of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Patients Treated By CAR T-Cells Therapy Thomas Gastinne, Amandine Le Bourgeois, Marianne Coste-Burel, Thierry Guillaume, Pierre Peterlin, Alice Garnier, et al. (+14)
108 [GO] Blood 2021―Nov―24 Sars-Cov-2 T-Cell Response in Allogeneic Hematopoietic Stem Cell Recipients Following Two Doses of BNT162b2 Vaccine Beatrice Clemenceau, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, et al. (+17)
109 [GO] Blood 2021―Nov―24 Safety and Tolerability of Sars-Cov-2 Vaccination and Natural History of Infection Among Patients with Castleman Disease Sheila K Pierson, Russell Perkins, Frits van Rhee, Corey Casper, David C Fajgenbaum
110 [GO] Blood 2021―Nov―24 Humoral and T Cell Immune Responses to Sars-Cov-2 Vaccination in Hematopoietic Cell Transplant Recipients Eleni Gavriilaki, Anastasia Papadopoulou, Tasoula Touloumenidou, Fani Stavridou, Evdoxia Koravou, Maria Giannaki, et al. (+10)
111 [GO] Blood 2021―Nov―24 Sars-Cov-2 Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria: An Italian Multicenter Survey Juri Alessandro Giannotta, Bruno Fattizzo, Corrado Girmenia, Claudia Ielo, Elisabetta Metafuni, Adele Visentin, et al. (+7)
112 [GO] Blood 2021―Nov―24 Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study Nathanael R Fillmore, Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Linden Huhmann, Summer S Han, et al. (+6)
113 [GO] Blood 2021―Nov―24 Assessment of Serology after Sars-Cov-2 Vaccine in Allogeneic HCT Recipients Melissa Baker, Maria Cortes, Jaeil Ahn, Michele L. Donato, Sukhdeep Kaur, Hyung C. Suh, et al. (+5)
114 [GO] Blood 2021―Nov―24 Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma Tanaya Shree, Vishnu Shankar, Debra K. Czerwinski, Gladys Rodriguez, Sara Beygi, Joseph G Schroers-Martin, et al. (+10)
115 [GO] Blood 2021―Nov―24 Safety and Efficacy of Sars-Cov-2 Vaccines in Hodgkin Lymphoma Patients Receiving PD-1 Inhibitors Jakub Svoboda, Hatcher J Ballard, Carrie I Ho, Mitchell E. Hughes, Elise A Chong, Adam Duca, et al. (+7)
116 [GO] Blood 2021―Nov―24 Responses to Sars-Cov-2 Vaccines in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia Akriti G Jain, Ning C. Dong, Somedeb Ball, Elaine S Tan, Junmin Whiting, Rami S. Komrokji, et al. (+7)
117 [GO] Blood 2021―Nov―24 Venetoclax with Azacitidine or Low Dose Cytarabine As an Alternative to Intensive Chemotherapy in Fit Adults during the COVID19 Pandemic: Real World Data from the UK National Health Service Jad Othman, Mariam Amer, Ruebina Amofa, Laura Anderson, Michael J Austin, Alex Bashford, et al. (+47)
118 [GO] Blood 2021―Nov―24 Antibody Response after 2 and 3 doses of SARS-CoV-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients Alexis Maillard, Rabah Redjoul, Marion Klemencie, Helene Labussiere-Wallet, Amandine Le Bourgeois, Maud D'Aveni, et al. (+13)
119 [GO] Blood 2021―Nov―23 ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19 Pablo Velasco, Filomena Longo, Andrea Piolatto, Eduardo J. Bardón-Cancho, Beatriz Ponce-Salas, Pagona Flevari, et al. (+44)
120 [GO] Blood 2021―Nov―23 Immature Platelets and Disease Severity in Patients Hospitalized with Acute COVID-19 Who Are Vaccinated Against COVID-19 Nicholas C.J. Lee, Haekyung Jeon-Slaughter, Ibrahim F. Ibrahim, Taha Bat, Sung-Hee Choi
121 [GO] Blood 2021―Nov―23 Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19 Shivani Rao, Nicole K. Yun, James L. Coggan, Peter Wu, Teresa O'Brien, Katherine Barnett, et al. (+8)
122 [GO] Blood 2021―Nov―23 Lymphocyte Ratios Progressively Worsen in Non-Survivors of COVID-19 Adekunle Emmanuel Alagbe, Gisele Audrei Pedroso, Beatriz Benedetti de Oliveira, Edivilson de Costa, Gisélia Aparecida Freire Maia, Bruna Facanali Piellusch, et al. (+7)
123 [GO] Blood 2021―Nov―23 Characterization of the Early Humoral and Cellular Response Developed in Oncohematological Patients Post-Vaccination with One Dose Against COVID-19 Magdalena Corona De Lapuerta, Sara Rodriguez-Mora, Guiomar Casado-Fernandez, Javier Garcia-Pérez, Lorena Vigon, María Aranzazú Murciano-Antón, et al. (+9)
124 [GO] Blood 2021―Nov―23 Neutrophil Metabolic Rewiring in Severe and Mild COVID-19 Yafeng Li, Jessica S Hook, Qing Ding, Stephen Chung, Jessica Moreland, Michalis Agathocleous
125 [GO] Blood 2021―Nov―23 Extended Thromboprophylaxis in Patients with COVID-19 Wei Zhao, Pin Li, Scott Kaatz, Katie Latack, Lonni Schultz, Laila Poisson
126 [GO] Blood 2021―Nov―23 Sars-Cov-2 Infection Promotes Endothelial Dysfunction and Thrombosis in a Mouse Model of COVID-19 Roberto Aiolfi, Jeanine Ahmed, Juan Carlos de la Torre, John H. Griffin, Laurent O. Mosnier
127 [GO] Blood 2021―Nov―23 Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19 Orly Leiva, Umberto Campia, Julia Snyder, Briana Barns, Samantha Rizzo, Candrika Khairani, et al. (+8)
128 [GO] Blood 2021―Nov―23 Success and Satisfaction with Virtual Hematology Curriculum Implemented in Response to COVID-19 Ali Noel Gunesch, Kristen McClellan, Gabrielle Meyers, Evan Shereck
129 [GO] Blood 2021―Nov―23 Optimal Anticoagulant Dosing in Patients with COVID-19, a Retrospective Review Alessandra Carrillo, Shil Punatar, Sushma Pavaluri, Madeline Jentink, Dixita Patel, Joseph Braun, et al. (+5)
130 [GO] Blood 2021―Nov―23 Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group Anne Mea Spanjaart, Per Ljungman, Rafael De La Camara, Gloria Tridello, Valentín Ortiz-Maldonado, Alvaro Urbano-Ispizua, et al. (+28)
131 [GO] Blood 2021―Nov―23 COVID-19 Among Patients with Hematological Malignancies: Experience from a Tertiary Center Showing Lower Than Expected Mortality and Establishing the Safety of in-Hospital Patient Care during the Pandemic Shlomzion Aumann, Uria Tsubary, Sarah Israel, Dina Ben Yehuda, David Lavie, Neta Goldschmidt, et al. (+10)
132 [GO] Blood 2021―Nov―23 Social Media Validation for Pre-Screened Ontologies As a Driver for Biomolecular Interaction Significance in COVID-19 and Hematological Malignancies Yan Leyfman, Samarth Sandeep, Peter Rizk, Carlo Khoury, Chandler Howard Park
133 [GO] Blood 2021―Nov―23 Association between Insufficient Interleukin-6 (IL-6) Inhibition and Worsening Outcomes in COVID-19 and Idiopathic Multicentric Castleman Disease (iMCD), and a Mathematical Model to Predict Optimal Dosing to Completely Block IL-6 Activity Jean-Francois Rossi, Hao-Chun Chiang, Zhao-Yang Lu, Kalle Levon, Frits van Rhee, Karan Kanhai, et al. (+2)
134 [GO] Blood 2021―Nov―23 COVID-19 and Sickle Cell Disease in the Province of Q: Morbidity and Mortality Rates Derived from the Provincial Registry Mathias Castonguay, Nawar Dakhallah, Marie-Laure Colaiacovo, Camille Jimenez-Cortes, Justin Desroches, Anne-Marie Claveau, et al. (+13)
135 [GO] Blood 2021―Nov―23 COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination Willy A. Flegel, Kshitij Srivastava, Valeria De Giorgi, Michael R Holbrook, Nicolai V Bovin, Stephen M Henry, Kamille West
136 [GO] Blood 2021―Nov―23 Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis Daria V Madeeva, Kelly Borges, Marcus Shallow, Prerak V Juthani, Stephen Y Wang, Akash Gupta, et al. (+3)
137 [GO] Blood 2021―Nov―23 Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study Hannah P Stevens, Rodrigo Canovas, Karlheinz Peter, Huyen Tran, Zane Kaplan, James David McFadyen
138 [GO] Blood 2021―Nov―23 Comparison of D-Dimer Level on Mild, Moderate and Severe COVID-19 at Immanuel Hospital Bandung City October 1 st - December 31 st, 2020 Hary Gustian, Regina Anjani Budi Pratiwi, Rini Riantie
139 [GO] Blood 2021―Nov―23 Four-Fold Increased Mortality from Sars-Cov-2 Infection in Patients with Hematologic Versus Non-Hematologic Malignancies Treated at the Largest Tertiary COVID-19 Center in Chicago/Rush University Medical Center (March 1, 2020-December 31,2020) Nicole K. Yun, Praneeth Chebrolu, Paul R. Yarnold, Joshua Thomas, James L. Coggan, Anmol Baranwal, et al. (+3)
140 [GO] Blood 2021―Nov―23 Severity of Covid-19 Clinical Outcomes and Mortality in Multiple Myeloma Patients over Year 1 of the Pandemic Joaquín Martínez-López, Maria-Victoria Mateos, Nieves López-Muñoz, Maria Alicia Senin Magan, Maria Dunia De Miguel, Ana López de la Guía, et al. (+21)
141 [GO] Blood 2021―Nov―23 Oxygenation and Inflammatory Markers after Early Covid-19 Convalescent Plasma: A Comparison of Survivors and Non-Survivors Valentina Baez Sosa, Ahmad M Nassar, Nikitha Vobugari, Anjali S Ghodasara, Cathy Conry-Cantilena, Glenn Wortmann, et al. (+6)
142 [GO] Blood 2021―Nov―23 Global Waldenström's Macroglobulinemia Patient-Derived Data Registry, Whimsical, Highlights Real-World Treatment Outcomes and COVID-19 Data Ibrahim Tohidi-Esfahani, Andrew Warden, Elena Malunis, Peter Liburdi deNardis, Michelle Postek, Shirley D'Sa, et al. (+7)
143 [GO] Blood 2021―Nov―23 COVID-19 Diagnosis and Its Impact on Thrombotic Risk in a Cohort of Patients Simultaneously Hospitalized Due to Acute Respiratory Distress Syndrome Andréa Coy-Canguçu, Gisele Aparecida Locachevic, João Carlos Silva Mariolano, Kaio Henrique De Oliveira Soares, José Diogo Oliveira, Camila de Oliveira Vaz, et al. (+5)
144 [GO] Blood 2021―Nov―23 A Rare Case of Mild COVID-19 Disease Associated with Type 1 Cryoglobulinemia and Thrombotic Thrombocytopenic Purpura Syed Mujtaba Naqvi, Carrisa Schwartz, Rachel Whittaker, Ghayth Hammad, Rishi Agarwal
145 [GO] Blood 2021―Nov―23 Targeting the Endothelium in the Treatment of COVID-19 Early Clinical Stages: Results of a Randomized Placebo-Controlled Trial Alejandro Gonzalez-Ochoa
146 [GO] Blood 2021―Nov―23 Patients with Multiple Myeloma and Prior COVID-19 Have Superior Antibody Responses Against Sars-Cov-2 Compared with Fully Vaccinated Myeloma Patients with the BNT162b2 Vaccine Maria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, et al. (+9)
147 [GO] Blood 2021―Nov―23 A Multicompartment Mathematical Model Based on Host Immunity for Dissecting COVID-19 Heterogeneity Jianghua Wu, Heng Mei, Jianwei Li, Jingpeng Zhang, Lu Tang, Mengyi Du, et al. (+2)
148 [GO] Blood 2021―Nov―23 Does Fibrin Structure Contribute to the Increased Risk of Thrombosis in COVID-19 ICU Patients? Judith Juliana De Vries, Chantal Visser, Lotte Geers, Johan A. Slotman, Henrik Endeman, Marieke J.H.A. Kruip, et al. (+2)
149 [GO] Blood 2021―Nov―23 COVID-19 in Children, Adolescents and Young Adults with Hematological Malignancies Rebecca S Parker, Jemily Malvar, Andrew Doan, Paibel Aguayo-Hiraldo, Chintan Parekh
150 [GO] Blood 2021―Nov―23 Humoral Response to mRNA Vaccines BNT162b2 and mRNA-1273 COVID-19 in Chronic Lymphocytic Leukemia Patients Cristina Bagacean, Rémi Letestu, Chadi Al Nawakil, Ségolène Brichler, Vincent Lévy, Nanthara Sritharan, et al. (+21)
151 [GO] Blood 2021―Nov―23 Clinical Outcomes of COVID-19 in Hematological Malignancies in Jordan : Tertiary Cancer Center Experience Hazim Ababneh, Fadwa Alqadi, Mohammad ma'Akoseh, Khalid Halahleh, Layan abo Abed, Mohammad Akkawi, Kamal Al-Rabi
152 [GO] Blood 2021―Nov―23 Outcomes of COVID-19 in Hematopoietic Stem-Cell Transplant Recipients: A Single Institution Observational Study Sami Dwabe, Lakshmi Savitala-Damerla, Jack Rodman, Abdullah Ladha, Eric Tam, Houda Alachkar, et al. (+3)
153 [GO] Blood 2021―Nov―23 COVID-19 in Multiple Myeloma Patients: Frequencies and Risk Factors for Hospitalization, Ventilatory Support, Intensive Care Admission and Mortality -Cooperative Registry from Grupo Brasileiro De Mieloma Multiplo (GBRAM) Marcia Garnica, Edvan De Queiroz Crusoe, Glaciano Ribeiro, Rosane Bittencourt, Roberto José Pessoa Magalhães, Karla Richter Zanella, et al. (+7)
154 [GO] Blood 2021―Nov―23 Results of a Single Center Survey on Vaccination Against COVID-19 in Patients with Chronic Myeloid Leukemia Ekaterina Yu. Chelysheva, Anna Petrova, Oleg A. Shukhov, Margarita Gurianova, Anastasiya Bykova, Irina Nemchenko, et al. (+3)
155 [GO] Blood 2021―Nov―23 COVID-19 in Patients with Chronic Myeloid Leukemia: Poor Outcomes for Patients with Comorbidities, Older Age, Advanced Phase Disease, and Those from Low-Income Countries: An Update of the Candid Study Katia B Pagnano, Chung Hoow Kok, Michael J. Mauro, Jorge E. Cortes, Nicola Evans, Qian Jiang, et al. (+7)
156 [GO] Blood 2021―Nov―23 Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell Guilherme Fleury Perini, Luis Villela, Brady E Beltran, Denisse Castro, Victoria Otero, Mariana Kalmus, et al. (+36)
157 [GO] Blood 2021―Nov―23 Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia Olga A. Gavrilina, Kristina A. Zakurdaeva, Anastasia N. Vasileva, Sergei Dubov, Vitaly S. Dubov, Vladimir I. Vorobyev, et al. (+19)
158 [GO] Blood 2021―Nov―23 COVID-19 Incidence in Asymptomatic Cancer Patients Undergoing Chemotherapy Claudia Monteiro, Cecília Gomes, Leticia Marani, Leandro Colli, Rodrigo T. Calado, Lorena Figueiredo-Pontes
159 [GO] Blood 2021―Nov―23 Randomized, Multi-Center, Double-Blinded, Placebo Controlled Safety and Early Efficacy Trial of Cryopreserved Cord Blood Derived T-Regulatory Cell Infusions (CK0802) in the Treatment of COVID-19 Induced ARDS. (RESOLVE Trial) Douglas E Gladstone, Christopher Howard, Mi-Ae Lyu, Jason Mock, Darryl Adams, Kevin Gibbs, et al. (+11)
160 [GO] Blood 2021―Nov―23 Spontaneous Heparin-Induced Thrombocytopenia and COVID-19 Infection Suneetha Amara
161 [GO] Blood 2021―Nov―23 Clinical Outcomes of COVID-19 Infection Among Children with Cancer: A Single-Center Experience Esra Akkoyun, Jesus Sotelo, Giselle Cherry, Maria Bisceglia, Tamra Slone, Victor Aquino, Paul Sue
162 [GO] Blood 2021―Nov―23 COVID-19 Infection and Outcomes at a Comprehensive Sickle Cell Center Fuad El Rassi, Abeer N. Abouyabis, Ross M. Fasano, Morgan L. McLemore
163 [GO] Blood 2021―Nov―23 Covid-19 Infection in Hematological Malignancies: Registry Data from India Arihant Jain, Lingaraj Nayak, Uday Prakash Kulkarni, Nikita Mehra, Uday Yanamandra, Smita Kayal, et al. (+20)
164 [GO] Blood 2021―Nov―23 Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration Program (Justin) Ching Ting Loke, Charlotte Gaskell, Sonia Fox, Rachel Fletcher, Catherine Thomas, Louise Hopkins, et al. (+32)
165 [GO] Blood 2021―Nov―23 COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey) Francesco Marchesi, Jon Salmanton-García, Alberto Lopez-Garcia, Giulia Dragonetti, Uluhan Sili, Andreas Glenthoej, et al. (+12)
166 [GO] Blood 2021―Nov―23 COVID-19 Infection of HSCT Recipients Is Associated with High Mortality but No Detectable Cytokine Storm at Presentation Giovanna Lucchini, Elena Cozma, Aimee Jackson, Kimberly Gilmour, Rachel Elizabeth Protheroe, Eleni Tholouli, et al. (+17)
167 [GO] Blood 2021―Nov―23 In Covid-19 Infection, Plasma Extracellular Vesicle Tissue Factor Activity Does Not Correlate with D-Dimer Levels Thomas J. Girard, Irem Eldem, Kenneth E Remy, Monty Mazer, Jorge Di Paola
168 [GO] Blood 2021―Nov―23 Acquired Aplastic Anemia in Immunocompetent Pediatric Patients with Asymptomatic COVID-19 Infection: A Case Series Jordan E. Fritch, Taylor Losole, Lindsey Leyden, Jiri Bedrnicek, Deborah A. Perry, Melissa A. Acquazzino, Chital Raulji
169 [GO] Blood 2021―Nov―23 Sickle Cell Disease and COVID-19 Infection: A Single-Center Experience Sindhu Devarashetty, Kimberly Le Blanc, Udhayvir Singh Grewal, Jacqueline Walton, Tabitha Jones, Runhua Shi, et al. (+3)
170 [GO] Blood 2021―Nov―23 Clinical Predictors of Outcome in Adult Patients with Acute Leukemias and Myelodysplastic Syndrome and COVID-19 Infection: Report from the American Society of Hematology Research Collaborative (ASH RC) Data Hub Pinkal Desai, Aaron D Goldberg, Kenneth C. Anderson, Varun Narendra, Donna S. Neuberg, Vivek Radhakrishnan, et al. (+10)
171 [GO] Blood 2021―Nov―23 Allogeneic and Autologous Hematopoietic Transplants Can be Safely Performed after COVID-19 Infections Jeremy L. Ramdial, Rima M. Saliba, Amin M. Alousi, Gabriela Rondon, Julianne Chen, Celina Ledesma, et al. (+3)
172 [GO] Blood 2021―Nov―23 Blood Type Does Not Affect Morbidity or Mortality in COVID-19 Infections, As Assessed By a Clinical Severity Scoring System Katharine E Thomas, Erin Marie Dauchy, Amber Karamanis, Andrew G. Chapple, Michelle M Loch
173 [GO] Blood 2021―Nov―23 COVID-19 Is Associated with Endothelial Dysfunction and Enhanced Plasma Thrombin Generation Despite Pharmacological Thromboprophylaxis Sarah Kelliher, Luisa Weiss, Sarah Cullivan, Ellen O' Rourke, Claire Murphy, Shane Toolan, et al. (+12)
174 [GO] Blood 2021―Nov―23 Complete Blood Count Parameters Outperform Putative Inflammatory Markers in Predicting COVID-19 Mortality: A Multimodal Machine Learning Model Precious Idogun, John Sia, Mindy Ward, Dillan Patel, Wilhelmine Wiese-Rometsch, Anjan J. Patel
175 [GO] Blood 2021―Nov―23 Antibody and T-Cell Responses to Covid-19 mRNA Vaccines in Patients with B-Cell Lymphomas and Chronic Lymphocytic Leukemia (CLL) Emily C. Ayers, Jeffrey Wilson, Glenda Canderan, Behnam Keshavarz, Judith Woodfolk, Craig A. Portell, Michael E. Williams
176 [GO] Blood 2021―Nov―23 The Impact of COVID-19 on Acute Myeloid Leukemia (AML) Treatment Patterns in the United States: Retrospective Analysis of an Electronic Medical Records (EMR) Database Clara Chen, David Rotter, Zephirin Kiendrebeogo, Ravi Potluri
177 [GO] Blood 2021―Nov―23 A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy Yun Choi, Jessica Caro, Xiaochun Li, Arshed Al-Obeidi, Sharyn Lynn Kurtz, Austin I. Kim, et al. (+16)
178 [GO] Blood 2021―Nov―23 Safety of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Patients with Multiple Myeloma Presenting with Extramedullary Disease during the COVID-19 Pandemic Meral Beksac, Tulin Tuglular, Ali Unal, Michele Cavo, Francesca Gay, Eirini Katodritou, et al. (+7)
179 [GO] Blood 2021―Nov―23 Cryopreservation of Allogeneic Hematopoietic Cell Grafts Did Not Adversely Affect Early Post-Transplant Survival during the First Six Months of the COVID-19 Pandemic Steven Devine, Michelle Kuxhausen, Stephen R. Spellman, Caitrin Fretham, Kwang Woo Ahn, Heather E. Stefanski, et al. (+3)
180 [GO] Blood 2021―Nov―23 Utilizing HealthTree ® Cure Hub's Real-World Data to Assess Treatment Management of Patients with Multiple Myeloma during the COVID-19 Pandemic Nathan W. Sweeney, Jennifer M. Ahlstrom
181 [GO] Blood 2021―Nov―23 Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic Shivani Rao, Nicole K. Yun, James L. Coggan, Peter Wu, Teresa O'Brien, Katherine Barnett, et al. (+8)
182 [GO] Blood 2021―Nov―23 Chronic Lymphocytic Leukemia (CLL) Patients Quality of Life (QoL): A Cross-Sectional Analysis of the Italian Experience in the Choice Study during the First Wave of the COVID-19 Pandemic Alessandra Tedeschi, Idanna Innocenti, Francesco Albano, Alessandro Gozzetti, Luciano Levato, Marika Porrazzo, et al. (+7)
183 [GO] Blood 2021―Nov―23 Successful Treatment of Acute Myeloid Leukemia with CPX-351 in 2 Patients in the United Kingdom during the COVID-19 Pandemic Sreetharan Munisamy, Satarupa Choudhuri
184 [GO] Blood 2021―Nov―23 Drepadom - Establishment of Home Care Services and Hospitalizations for Sickle Cell Disease Patients As Standard Care Since the Covid-19 Pandemic Yanís Pelinski, Cindy Mescam, Christian Kassasseya, Gonzalo De Luna, Henri Guillet, Clara Noizat, et al. (+10)
185 [GO] Blood 2021―Nov―23 Potential Benefits of a 6-Week Exercise and Mindfulness-Based Telehealth Training for HCT Survivors to Meet the Challenges of the COVID-19 Pandemic - a Feasibility Study David Ma, David Kliman, Kate Fennessy, Nikki Molan
186 [GO] Blood 2021―Nov―23 Clinical Profile and Outcome of COVID Positive Hematology Patients during the COVID-19 Pandemic - an Analytical Cross Sectional Study from a Tertiary Care Centre in India Faisal Kassim, Chirag Sunil Lalwani, Hamsini Movva, Sani Kodathumuriyil Sunny, Merlin Moni, Remya Sudevan, et al. (+5)
187 [GO] Blood 2021―Nov―23 A Survey Conducted during COVID-19 Pandemic Among Brazilian Chronic Myeloid Leukemia and Philadelphia-Negative Myeloproliferative Neoplasms Patients Leonardo Fechio, Ana Vitória Ferreira Mota, Jaisson Bortolini, Gislaine B O Duarte, Marcia Delamain, Samuel S Medina, et al. (+5)
188 [GO] Blood 2021―Nov―23 Virtual Care during the COVID-19 Pandemic Among Patients with Hematologic Malignancies - a Princess Margaret Cancer Centre Experience Adam Suleman, Abi Vijenthira, Tran Trong, Alejandro Berlin, Anca Prica, Danielle Rodin
189 [GO] Blood 2021―Nov―23 Racial Disparities in Telemedicine Uptake during the COVID-19 Pandemic Among Patients with Hematologic Malignancies in the United States Natalia Neparidze, Krystal W. Lau, Xiaoliang Wang, Amy J. Davidoff, Scott F. Huntington, Omer Hassan Jamy, et al. (+8)
190 [GO] Blood 2021―Nov―23 Effect of COVID-19 Pandemic Control Measures on Diagnoses of Hematologic Cancer Among CMS Population in 2020 Dave Smart, Wendy Moore, Karina Hjort, Karen Keating, Bob Holt, Raymond Henderson, et al. (+4)
191 [GO] Blood 2021―Nov―23 COVID-19 Pandemic Impact on Chronic Lymphocytic Leukemia (CLL) Patients' Preferences Towards Therapies: The Italian Experience (CHOICE Study) Stefano Molica, Luca Laurenti, Paolo Ghia, Marta Coscia, Antonio Cuneo, Gianluca Gaidano, et al. (+9)
192 [GO] Blood 2021―Nov―23 Impact of the COVID-19 Pandemic on Acute Care Visits for Patients with Sickle Cell Disease Dennis Orkoulas-Razis, Nicholas Bishop, Ellen Dupont, Maria R. Baer, Richard Gentry Wilkerson, Jennie Y. Law
193 [GO] Blood 2021―Nov―23 Effects of the COVID-19 Pandemic on Caregivers of Young Children with Sickle Cell Disease Enrolled in the Engage-HU Trial Anna M Hood, Aimee K Hildenbrand, Joanna Rebitski, Jasmine Stallworth, Yolanda Johnson, Stacey Gomes, et al. (+17)
194 [GO] Blood 2021―Nov―23 Impact of COVID-19 Pandemic on Global Unrelated Stem Cell Donations in 2020 - Report from World Marrow Donor Association Monique Jöris, Stefanie Bernas, Alexander H. Schmidt, Jay Feinberg, Nicoletta Sacchi, Heidi Elmoazzen, et al. (+14)
195 [GO] Blood 2021―Nov―23 Impact of the COVID-19 Pandemic on in-Person Visit Rates Among Patients with Hematologic Malignancies in the United States Gaurav Goyal, Krystal W. Lau, Xiaoliang Wang, Amy J. Davidoff, Scott F. Huntington, Omer Hassan Jamy, et al. (+8)
196 [GO] Blood 2021―Nov―23 Impact of the COVID-19 Pandemic on Primary Care Access for Patients with Hematologic Malignancies Ying Ling, Kelvin Chan, Aditi Patrikar, Ning Liu, Aisha Lofters, Colleen Fox, et al. (+2)
197 [GO] Blood 2021―Nov―23 The Impact of the COVID-19 Pandemic on Quality of Life in Danish Patients with Multiple Myeloma; Results from an Ongoing Longitudinal National Survey Louise Redder, Sören Möller, Anna Thit Johnsen, Mary Jarden, Christen lykkegaard Andersen, Henrik Frederiksen, et al. (+9)
198 [GO] Blood 2021―Nov―23 Impact of the Covid-19 Pandemic on Quality of Life of Patients with CML Hubert Wysoglad, Elzbieta Szczepanek, Ositadima Chukwu, Weronika Lebowa, Wiktor Nowak, Tomasz Sacha
199 [GO] Blood 2021―Nov―23 The Impact of the COVID-19 Pandemic on the Diagnosis and Management of Patients with Classical Hodgkin Lymphoma: A Single-Center Experience Selin Kucukyurt, Kübra Şahin, Umut Yılmaz, Abdülkadir Erçalışkan, Tuba Özkan Tekin, Damla Ortaboz, et al. (+6)
200 [GO] Blood 2021―Nov―23 Changes in Multiple Myeloma Treatment Patterns during the Early COVID-19 Pandemic Period Natalia Neparidze, Rong Wang, Amer M. Zeidan, Nikolai Podoltsev, Rory M. Shallis, Xiaomei Ma, et al. (+2)
201 [GO] Blood 2021―Nov―23 Gilteritinib for Relapsed Acute Myeloid Leukaemia with FLT3 Mutation during the COVID-19 Pandemic: Real World Experience from the UK National Health Service Jad Othman, Usman Afzal, Ruebina Amofa, Michael J Austin, Alex Bashford, Edward Belsham, et al. (+36)
202 [GO] Blood 2021―Nov―23 The Impact of Degree of Anticoagulation on Thrombotic and Other Complications in Hospitalized COVID-19 Patients Rena Zheng, Alexandra Solomon, Madeline DiLorenzo, Iniya Rajendran, Joseph Park, Vrushali Dhongade, et al. (+6)
203 [GO] Blood 2021―Nov―23 Assessment of Macrophage Inflammatory Biomarkers and Neutrophil Extracellular Traps Associated Proteins in COVID-19 Patients Laura Lopez de Frutos, Irene Serrano-Gonzalo, Barbara Menendez-Jandula, Esther Franco-Garcia, Carlos Lahoz, Paz Latre, et al. (+2)
204 [GO] Blood 2021―Nov―23 Ethnic Variation in Hospitalized COVID-19 Patients and Correlation with Coagulopathy, Thrombosis, Prognosis and 30 Day Mortality Outcomes in California's Central Valley Charity A Huang, Omar Mahmood, Paul Mills, Mehdia Amini, Sundeep Bekal, Jason Doornenbal, et al. (+3)
205 [GO] Blood 2021―Nov―23 Red Blood Cells from COVID-19 Patients Show Evidence of Increased Oxidative Stress and Increased Lactate Influx Philip Murphy, Edel Mullen, Stephen Bergin, Geraldine Healy, Michelle Lavin, John Quinn, Siobhan Glavey
206 [GO] Blood 2021―Nov―23 Thrombotic Events in COVID-19 Patients Undergoing Convalescent Plasma Therapy: A Systematic Review Philip Yu, Faran Khalid, Allen Li, Marissa Laureano, Mark Crowther
207 [GO] Blood 2021―Nov―23 Whole Blood Adhesion to VCAM-1 and P-Selectin and RBC Mechanical Fragility Can be Compromised in Long COVID-19 Patients with Sickle Cell Disease Michael Tarasev, Marta Ferranti, Cidney Allen, Xiufeng Gao, Kayla Topping, Marta Ferranti, et al. (+3)
208 [GO] Blood 2021―Nov―23 Treatment of COVID-19 Patients: Insights into the Use of Bone Marrow-Derived Mesenchymal Stem Cells Heitor Duarte Andrade, Andrea Tiemi Kondo, Lucila Kerbauy, Raquel de Melo Alves Paiva, Denise Cristine Oliveira, Larissa Leggieri Coa, et al. (+7)
209 [GO] Blood 2021―Nov―23 Early Immune Profile Assessment By Flow Cytometry Predicts Severe COVID-19 Pneumonia Abora Rial-Villavecchia, Maria Teresa Asensi, Carme Giménez-Argente, Joan Gómez-Junyent, Juan Jose Rodriguez-Sevilla, Leonor Arenillas, et al. (+5)
210 [GO] Blood 2021―Nov―23 Multi-Arm Trial of Inflammatory Signal Inhibitors (MATIS) for Hospitalised Patients with Mild or Moderate COVID-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomised Controlled Trial Asad Charania, Nikhil Vergis, Rachel Phillips, Victoria Cornelius, Alexia Katsarou, Taryn Youngstein, et al. (+14)
211 [GO] Blood 2021―Nov―23 Use of Defibrotide in Patients with COVID-19 Pneumonia; Results of the Defi-VID19 Phase 2 Trial Annalisa Ruggeri, Antonio Voza, Carmine Liberatore, Gloria Catalano, Francesco Corrado, Luigi Di Filippo, et al. (+16)
212 [GO] Blood 2021―Nov―23 An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy Adrienne Kaufman, Yael Kusne, Molly Klanderman, Heidi E. Kosiorek, Thomas Oliver, Miguel Gonzalez-Velez, et al. (+4)
213 [GO] Blood 2021―Nov―23 Online Patient-Reported Platform Detects Trend of Increased COVID-19 Risk and Severity for Multiple Myeloma Patients on Active Lenalidomide-Based Therapy Emily I. Liu, Nathan W. Sweeney, Jennifer M. Ahlstrom
214 [GO] Blood 2021―Nov―23 Multiple Myeloma, Clinical Characteristics, and Increased COVID-19 Risk Using Real-World Data Emily I. Liu, Nathan W. Sweeney, Jennifer M. Ahlstrom
215 [GO] Blood 2021―Nov―23 Meta-Analysis of D-Dimer, hsCRP and Cytokines in COVID-19 Severe/Critical Patients in China Jie Zhang, Lidong Zhao, Gang Wang, Linhua Yang
216 [GO] Blood 2021―Nov―23 Acute and Post-Acute COVID-19 Severity and Mortality in Patients with Hematologic Malignancies: A Population-Based Registry Study Joaquin Martinez-Lopez, Javier De La Cruz, Rodrigo Gil-Manso, Angel Cedillo, Adrian Alegre, Maria Pilar Llamas Sillero, et al. (+24)
217 [GO] Blood 2021―Nov―23 Identification of Complement-Related Missense Variants in Pediatric Patients with Acute and Post COVID-19 Syndromes Eleni Gavriilaki, Tasoula Touloumenidou, Stefanos Tsiftsoglou, Athanasios Tragiannidis, Evangelia Farmaki, Paraskevi Panagopoulou, et al. (+15)
218 [GO] Blood 2021―Nov―23 CAR-NK Cells Targeting Sars-Cov-2 Glycosites As COVID-19 Treatment Ilias Christodoulou, Ruyan Rahnama, Wesley J. Ravich, Jaesung Seo, Sergey Zolov, Andrew Marple, et al. (+2)
219 [GO] Blood 2021―Nov―23 Thrombocytopenia with and without Thrombosis Following COVID-19 Vaccination Melissa Ge, Danyal Ladha, Jennifer Lymer, Stefana Pancic, Marc Carrier, Gregoire Le Gal, Lana A Castellucci
220 [GO] Blood 2021―Nov―23 Relapsed Refractory Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Following COVID-19 Vaccination Michael T. Francisco, Adrienne E. Kaufman, Donald Northfelt, Leslie Padrnos, Allison C. Rosenthal, Jennifer Andres, et al. (+3)
221 [GO] Blood 2021―Nov―23 Patients with Multiple Myeloma on Anti-CD38 or Anti-BCMA Based Regimens and Patients with Waldenstrom's Macroglobulinemia Under Rituximab or BTK Inhibitors Have a Poor Humoral Response Following COVID-19 Vaccination Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, et al. (+10)
222 [GO] Blood 2021―Nov―23 COVID-19 Vaccination after Allogeneic Stem Cell Transplantation: Real Word Data on Safety and Efficacy. a Single Center Experience. Adela Neagoie, Charlotte Sommer, Andrea Gantner, Verena Wais, Jacqueline Schnell, Hannah Simon, et al. (+4)
223 [GO] Blood 2021―Nov―23 Anti-Spike (S) Antibody Production Post Covid-19 Vaccination after B Cell Depleting Therapy (BCDT) for Non-Hodgkin Lymphoma (NHL) Josselyn Glamyr Molina
224 [GO] Blood 2021―Nov―23 Seroconversion Rates after COVID-19 Vaccination Amongst Patients with Hematologic Malignancies: Results of a Rapid Vaccination and Evaluation Program in a Minority Rich, Ethnically Diverse Inner City Cohort Lauren C Shapiro, Radhika Gali, Astha Thakkar, Jesus D Gonzalez-Lugo, Abdul Hamid Bazarbachi, Shafia Rahman, et al. (+14)
225 [GO] Blood 2021―Nov―23 BNT162b2 mRNA COVID-19 Vaccination (BNTCV) in Patients (Pts) Having Hematological Malignancies (HM): Early tolerance with telemedicine application connecting and antibody anti-Spike IgG response (AcAS) Jean-Francois Rossi, Emmanuel Bonnet, Marion Velensek, Emma Wisniewski, Sophie Heraud, Rania Boustany, et al. (+7)
226 [GO] Blood 2021―Nov―23 For Better or for Worse: COVID-19 Vaccination during or Early after (Immuno-) Chemotherapy or Hematopoietic Progenitor Cell Transplantation Sabine Haggenburg, Birgit I. Lissenberg-Witte, Robert S. Van Binnendijk, Gerco Den Hartog, Bhoekhan S. Michel, Nienke J.E. Haverkate, et al. (+12)
227 [GO] Blood 2021―Nov―23 COVID-19 Vaccination in Adults with Immune Thrombocytopenia (ITP): Data from the Platelet Disorder Support Association (PDSA) Patient Registry Jennifer MacWhirter - DiRaimo, Caroline Kruse, James B Bussel, Alexandra Kruse
228 [GO] Blood 2021―Nov―23 Factors Associated with Seroconversion after COVID-19 Vaccination in Patients with Hematologic Malignancies Thomas A. Ollila, Rebecca Masel, John L Reagan, Kimberly Paiva, Shaolei Lu, Ralph Rogers, et al. (+6)
229 [GO] Blood 2021―Nov―23 Immunogenicity of Covid-19 Vaccination in Subjects with Myelodysplastic Syndromes Jennifer Vidler, Thanussuyah Alaguthurai, Sultan Abdul-Jawad, Sivalekha Viramuthu, Richard Beatson, Rosalind Graham, et al. (+3)
230 [GO] Blood 2021―Nov―23 Adverse Events Following COVID-19 Vaccination in Transfusion-Dependent -Thalassemia Patients Polyxeni Delaporta, Eugenia Lampropoulou, Anastasia Moschoviti, Ilona Binenbaum, Dimitra Kyriakopoulou, Natalia Ioakeimidou, et al. (+3)
231 [GO] Blood 2021―Nov―23 The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists Chantal Visser, Joseph S. Biedermann, Melchior C. Nierman, Felix J. M. Van der Meer, Anouk J. W. Gulpen, Yvonne C. F. Moors, et al. (+4)
232 [GO] Blood 2021―Nov―23 Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma Julia E. Wiedmeier, Madiha Iqbal, Javier Munoz, Evandro D. Bezerra, Juan Esteban Garcia Robledo, Radhika Bansal, et al. (+26)
233 [GO] Blood 2021―Nov―23 Autoimmune Cytopenias and Covid-19 Vaccination: Relapse and Suggested Treatment Gregorio Campos-Cabrera, Francisco-Gerardo Torres-Salgado, Salvador Campos-Cabrera, Jose-Luis Campos-Villagomez, Virginia Campos-Cabrera
234 [GO] Blood 2021―Nov―23 Deep Vein Thrombosis after COVID-19 Vaccinations Damon E. Houghton, Anand Padmanabhan, Aneel A. Ashrani, Ewa Wysokinska, Rahul Chaudhary, Leslie Padrnos, et al. (+4)
235 [GO] Blood 2021―Nov―23 Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL Clare Sun, Erika M Gaglione, Lauren T Vaughn, Rui Mu, Chingiz Underbayev, Jonathan Chen, et al. (+2)
236 [GO] Blood 2021―Nov―23 A Clue to Better Select Chronic Lymphocytic Leukemia Patients with Optimal Response to BNT162b2 mRNA COVID-19 Vaccine Stefano Molica, Diana Giannarelli, Mirella Lentini, Daniela Zappala, Daniela Loiacono, Valentina Gianfelici, et al. (+4)
237 [GO] Blood 2021―Nov―23 Serological Response to the BNT162b2 mRNA or Chadox-Ncov-19 COVID-19 Vaccine after First and Second Doses in Plasma Cell Disorder Patients: Influence of Host and Disease Factors Wei Yee Chan, Lara Howells, William Wilson, Emilie Sanchez, Louise Ainley, Selina J Chavda, et al. (+16)
238 [GO] Blood 2021―Nov―23 Social and Demographic Factors Contributing to COVID-19 Vaccine Hesitancy in Patients with Hematologic Malignancies Karen Sweiss, Meredith Russell, Gregory S Calip, Ryan Nguyen, Meshaal Khan, Eshana Shah, et al. (+9)
239 [GO] Blood 2021―Nov―23 Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia Gilad Itchaki, Lior Rokach, Ohad Benjamini, Osnat Bairey, Adi Sabag, Helly Vernitsky, et al. (+6)
240 [GO] Blood 2021―Nov―23 The Effect of COVID-19 Vaccine in Patients with Immune Thrombocytopenia Chantal Visser, Maurice Swinkels, Erik D. van Werkhoven, F. Nanne Croles, Heike Noordzij, Matthijs Eefting, et al. (+10)
241 [GO] Blood 2021―Nov―23 Oral Ixazomib in Untreated Follicular Lymphoma Permits COVID-19 Vaccine Response and Its Efficacy Is Associated with Clinical Factors and Gene Expression Signatures Solomon A. Graf, Ryan C. Lynch, Chaitra S. Ujjani, Ted A Gooley, David G. Coffey, Andrew J. Cowan, et al. (+8)
242 [GO] Blood 2021―Nov―23 Impaired mRNA Based COVID-19 Vaccine Response in Patients with B-Cell Malignancies after CD19 Directed CAR-T Cell Therapy Saurabh Dahiya, Tim Luetkens, Stephanie Avila, Saurabh Dahiya, Philip Margiotta, Kim Hankey, et al. (+12)
243 [GO] Blood 2021―Nov―23 COVID-19 Vaccine Response in Patients with Hematologic Malignancy: A Systematic Review and Meta-Analysis Inna Gong, Abi Vijenthira, Stephen Betschel, Lisa K. Hicks, Matthew Cheung
244 [GO] Blood 2021―Nov―23 Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy Shipra Goel, Juan J. Gu, Pallawi Torka, Cory Mavis, Suchitra Sundaram, Mirdza Neiders, et al. (+7)
245 [GO] Blood 2021―Nov―23 COVID-19 Vaccine Responsiveness in Patients with Multiple Myeloma and Waldenström Macroglobulinemia Andrew R. Branagan, Matthew M Lei, Jenny S Maron, Andrew J Yee, Elizabeth O'Donnell, Jorge J. Castillo, et al. (+20)
246 [GO] Blood 2021―Nov―23 Timing and Immune Status after Cellular Therapies Predict Response to COVID-19 Vaccines Roni Tamari, Ioannis Politikos, David Knorr, Santosha Vardhana, Jennifer Young, Leeann Marcello, et al. (+12)
247 [GO] Blood 2021―Nov―23 Biomarkers for Thrombosis in COVID-19: A Role for High Sensitivity Troponin-I and Immature Platelet Fraction? Bilal Ashraf, Haekyung Jeon-slaughter, Christopher Webb, Nicholas C.J. Lee, Weina Chen, Sung-Hee Choi, et al. (+2)
248 [GO] Blood 2021―Nov―23 Loss of an Immunodominant HLA-Α *01:01 Restricted Epitope for CD8+ Cytotoxic T Lymphocytes (CTLs) in the Delta Variant of COVID-19: An Example of Immunologic Escape and Implications for Immunologic Treatment Neal Flomenberg, Dolores Grosso, Yuri Sykulev, Nadezhda Anikeyeva, Yanping Huang, Michael Sun, et al. (+13)
249 [GO] Blood 2021―Nov―23 Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece Nikolaos Spyridis, Georgios Karavalakis, Despina Mallouri, Ioannis Eftychidis, Panagiotis Dolgyras, Niki Stavroyianni, et al. (+5)
250 [GO] Blood 2021―Nov―23 Acute Leukemia and COVID-19: The Johns Hopkins Experience Karin Paige Miller, Patrick A. Brown, B. Douglas Smith, Jonathan Webster, Helen Powell, Amy S. Duffield
251 [GO] Blood 2021―Nov―23 The Experience of the Cooperation in Science and Technology European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias (COST EuNet-INNOCHRON) Action and the Sweden Experience in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Era Michail Spanoudakis, David C. Dale, Emily Tran, Marije Bartels, Suncica Kapor, Daniela Guardo, et al. (+6)
252 [GO] Blood 2021―Nov―23 Evaluation of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunizations in Patients with B-Cell Malignancies Mukul Singal, Sanjana Kalvehalli Kashinath, S Shahzad Mustafa, Edward Walsh, Karthik Vadamalai, Saad Jamshed
253 [GO] Blood 2021―Nov―23 Rapid Disappearance of Lupus Anticoagulant in Novel Coronavirus 2019 Patients; Is It the Key to Pandora's Box? Hyunji Kim, Seongsoo Jang
254 [GO] Blood 2021―Nov―23 A Phase I/II Dose-Escalation Multi-Center Study to Evaluate the Safety of Infusion of Natural Killer Cells or Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia: (RELEASE NCT04578210) Antonio Pérez-Martínez, Alejandro Martín-Quirós, Cristina Ferreras, Karima Al-Akioui, Marta Mora-Rillo, Rosa Goterris, et al. (+17)
255 [GO] Blood 2021―Nov―23 Sars-Cov-2 Antibody Levels in Blood Cancer Patients after a Third Sars-Cov-2 "Booster" Vaccination - Observational Data from the LLS National Registry Lee M Greenberger, Larry A Saltzman, Jonathon W Senefeld, Patrick W Johnson, Louis J DeGennaro, Gwen L Nichols
256 [GO] Blood 2021―Nov―23 Sars-Cov-2 Antibody Decay Monitoring in mRNA Vaccinated Multiple Myeloma Patients Samuel D. Stampfer, Marissa-Skye Goldwater, Bernard Sean S. Regidor, Scott Kristian Jew, Sean Elliott Bujarski, Haiming Chen, et al. (+10)
257 [GO] Blood 2021―Nov―23 Chronic Graft-Versus-Host Disease (cGVHD) Exacerbation after Sars-Cov-2 Covid Vaccination Andrew D. Trunk, Samuel Shewan, Catherine J. Lee, Daniel R. Couriel
258 [GO] Blood 2021―Nov―23 Low Frequency of T Cell and Antibody Responses to Vaccination Against Sars-Cov-2 in Patients Post Allogeneic Stem Cell Transplantation in Comparison with Chronic Myeloid Malignancy Patients Patrick Harrington, Katie Doores, Chandan Saha, Jamie Saunders, Deepti H. Radia, Shahram Kordasti, et al. (+14)
259 [GO] Blood 2021―Nov―23 Antibody Response after Vaccination for Sars-Cov-2 in Patients with AL Amyloidosis and the Impact of Therapy Efstathios Kastritis, Evangelos Terpos, Aimilia D. Sklirou, Foteini Theodorakakou, Despina Fotiou, Eleni-Dimitra Papanagnou, et al. (+9)
260 [GO] Blood 2021―Nov―23 Neutralizing Antibody Responses Against Sars-Cov-2 in Patients with Plasma Cell Disorders Who Are on Active Treatment after Two Doses of mRNA Vaccination Al-Ola Abdallah, Zahra Mahmoudjafari, Meera Mohan, Joseph P. McGuirk, Cassie Remker, Margaret Foss, et al. (+4)
261 [GO] Blood 2021―Nov―23 Sars-Cov-2 Induced Endotheliopathy and the Impact on Clinical Outcomes in Critically Ill Pediatric Patients Shreya Agarwal, Mark Zobeck, Clay T Cohen, Sarah E Sartain
262 [GO] Blood 2021―Nov―23 Incidence of Sars-COV-2 Infection in Sickle Cell Patients Presenting with a Painful Crisis, a 12 Month Prospective Cohort Study Kadère Konté, Erfan Nur, Man Wai Tang, Jarom Heijmans, Charlotte F.J. Van Tuijn, Bart J. Biemond
263 [GO] Blood 2021―Nov―23 The Role of PF4 Antibodies in Pediatric Sars-Cov-2 Infections Meady Chiem, Lubica Rauova, Caroline Diorio, Kevin O McNerney, Hamid Bassiri, Kathleen Sullivan, et al. (+3)
264 [GO] Blood 2021―Nov―23 Clinical and Immunological Assessment of Patients with Sars-Cov-2 Infections Aditi Singh, Natali Salaytah, Daniel Lebovic, Zeyad Sako, Zachary Pounders, Laura Kohler, et al. (+4)
265 [GO] Blood 2021―Nov―23 Interest of a Third Dose of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Stem-Cells Recipients Amandine Le Bourgeois, Marianne Coste-Burel, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Berthe-Marie Imbert, et al. (+14)
266 [GO] Blood 2021―Nov―23 Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment Oliver Van Oekelen, Sarita Agte, Adolfo Aleman, Bhaskar Upadhyaya, Charles R. Gleason, Komal Srivastava, et al. (+17)
267 [GO] Blood 2021―Nov―23 Serologic Responses Following Sars-Cov-2 Vaccination and Factors Influencing It in Patients with Hematological Malignant and Non-Malignant Diseases - a Prospective Multicentric Study Zrinka Sertić, Marko Lucijanic, Sandra Bašić-Kinda, Ranka Serventi Seiwerth, Vlatka Periša, Dubravka Sertić, et al. (+7)
268 [GO] Blood 2021―Nov―23 Monitoring of Patients with Autoimmune Cytopenias during Sars-Cov-2 Vaccination Campaign: The Experience of a Reference Center Bruno Fattizzo, Juri Alessandro Giannotta, Nicola Cecchi, Paola Bianchi, Wilma Barcellini
269 [GO] Blood 2021―Nov―23 Antibody Response to Sars-Cov-2 Vaccination in Patients Following Allogeneic Hematopoietic Cell Transplantation Caroline Cicin-Sain, Alice Huang, Chloe Pasin, Selina Epp, Nicolas J Mueller, Jakob Nilsson, et al. (+12)
270 [GO] Blood 2021―Nov―23 Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia Eun-Ju Lee, Marina Beltrami Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer MacWhirter - DiRaimo, Terry B. Gernsheimer, et al. (+13)
271 [GO] Blood 2021―Nov―23 Increase in Antibody Titers Following Sars-Cov-2 Vaccination Remains Limited for More Than 3 Years after Final Dose of Anti-CD20 Antibody Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Hironori Sakai, Wataru Hojo, Marika Watanabe, et al. (+17)
272 [GO] Blood 2021―Nov―23 Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Francesco Saraceni, Alessandro Fiorentini, Sonia Morè, Selene Guerzoni, Bruna Puglisi, Benedetta Corvaro, et al. (+25)
273 [GO] Blood 2021―Nov―23 Profound B-Cell Lymphopenia Is a Major Factor Predicting Poor Humoral Response after BNT162b2 mRNA Sars-Cov-2 Vaccines in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Maxime Jullien, Amandine Le Bourgeois, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Marie Audrain, et al. (+16)
274 [GO] Blood 2021―Nov―23 Inhibition of Sars-Cov-2 Viral Replication and In Vivo Thrombus Formation By a Novel Plant Flavonoid Moua Yang, Lin Lin, Christina Scartelli, Da-Yuan Chen, Anika Patel, Roelof Bekendam, et al. (+3)
275 [GO] Blood 2021―Nov―23 Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study Patrick Van Dreden, Joseph Gligorov, Evangelos Terpos, Mathieu Jamelot, Michele Sabbah, Despina Fotiou, et al. (+8)
276 [GO] Blood 2021―Nov―23 Comparison of Clinical and Thrombotic Outcomes in Sars-Cov-2- Pneumonia Versus Other Viral Pneumonia in an Urban Academic Medical Center Rachel N. Goldberg, Kevin Johns, William Ye, Jeff J. Mucksavage, John G. Quigley, Nancy L. Shapiro, et al. (+4)
277 [GO] Blood 2021―Nov―23 Poor Neutralizing Antibody Responses in Patients with CLL, NHL and HL after Vaccination Against Sars-Cov-2; A Prospective Study in 132 Patients Evangelos Terpos, Maria Gavriatopoulou, Despina Fotiou, Chara Giatra, John V. Asimakopoulos, Maria Dimou, et al. (+12)
278 [GO] Blood 2021―Nov―23 Sars-CoV2 Antibody Responses in Patients with Hematological Malignancies Following Anti-CD20 Therapy Veronica A Guerra, Marisol Ocampo, Mike Cusnir
279 [GO] Blood 2021―Nov―23 Adoptive Immune Responses to Sars-Cov2 Vaccination in CART19 Treated Patients Kalpana Parvathaneni, Kyabeth Toress-Rodriguez, Wenzhao Meng, James Knox, Xiaoming Xu, Daniela Weiskopf, et al. (+9)
280 [GO] Blood 2021―Nov―23 A Case Series of Acquired Factor Inhibitor Following Sars-COV2-Vaccination Sriraksha Jayananda
281 [GO] Blood 2021―Nov―23 Optimizing Viable CD34 + Enumeration in Cryopreserved HPC Samples for Implementation of an External QA Program - Relevance to the Current Pandemic Scott J Ragg, Annabella Chang, David Ma
282 [GO] Blood 2021―Nov―23 Impact of COVID 19 Pandemic on Health Care Utilization for Patients with Sickle Cell Disease - a Specialty Treatment Center Experience Akshat Jain, Amie Patel, Udochukwo Oyoyo, Seth Wiafe
283 [GO] Blood 2021―Nov―23 Updated Outcomes during the Pandemic: Relationship between CD34and CD3 Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation Using Post Transplant Cytoxan: A Single Center Experience Anastasia Martynova, Krithika Chennapan, Jack Rodman, Mindy Hsiao, Abdullah Ladha, Eric Tam, et al. (+3)
284 [GO] Blood 2021―Nov―23 Determining the Rate of Anti-PF4 Antibody Positive Results in Patients Presenting with Venous Thrombosis but a Normal Platelet Count Following ChAdOx1 Ncov-19 Astrazeneca Vaccination: An Australian Combined State Testing Centre Experience Emma J Leitinger, Joanne Clifford, Michael Parker, Amanda Iacobelli, Pauline Sung, Vivien Chen, et al. (+10)
285 [GO] Blood Advances 2021―Nov―08 COVID-19 and CAR-T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP Alessandro Busca, Jon Salmanton-García, Paolo Corradini, Francesco Marchesi, Alba Cabirta, Roberta Di Blasi, et al. (+23)
286 [GO] Blood 2021―Nov―08 COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alberto Lopez-Garcia, Sylvain Lamure, Federico Itri, et al. (+30)
287 [GO] Blood 2021―Nov―04 COVID-19 in patients with CLL: how can we change the odds? Yair Herishanu, Chava Perry
288 [GO] Blood Advances 2021―Nov―02 American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+47)
289 [GO] Blood Advances 2021―Nov―01 SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia Jacob Appelbaum, Donald M. Arnold, John G. Kelton, Terry B Gernsheimer, Stefan D Jevtic, Nikola Ivetic, et al. (+2)
290 [GO] Blood 2021―Oct―25 COVID-19 Convalescent plasma Aaron Tobian, Claudia S Cohn, Beth Shaz
291 [GO] Blood 2021―Oct―20 Effectiveness of the BNT162b2mRNA Covid-19 Vaccine in Patients with Hematological Neoplasms Moshe Mittelman, Ori Magen, Noam Barda, Noa Dagan, Howard S Oster, Avi Leader, Ran Balicer
292 [GO] Blood Advances 2021―Oct―18 A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study Carlo Visco, Luigi Marcheselli, Roberto Mina, Marianna Sassone, Anna Guidetti, Domenico Penna, et al. (+51)
293 [GO] Blood 2021―Oct―07 COVID-19 and VITT: same or different? Gowthami M. Arepally
294 [GO] Blood Advances 2021―Oct―06 Six Months Antibody Persistence after BNT162b2 mRNA COVID-19 Vaccination in Patients with Chronic Lymphocytic Leukemia Yair Herishanu, Irit Avivi, Shai Levi, Gabi Shefer, Yotam Bronstein, Miguel Morales Moshiashvili, et al. (+4)
295 [GO] Blood 2021―Sep―29 SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients Eun-Ju Lee, Marina Beltrami Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer DiRaimo, Terry Gernsheimer, et al. (+13)
296 [GO] Blood 2021―Sep―29 Insights in ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) Andreas Greinacher, Kathleen Selleng, Raghavendra Palankar, Jan Wesche, Stefan Handtke, Martina Wolff, et al. (+25)
297 [GO] Blood Advances 2021―Sep―28 Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection Lauren E. Merz, Kavita Mistry, Donna Neuberg, Revital Freedman, Gerda Menard, David M. Dorfman, et al. (+3)
298 [GO] Blood Advances 2021―Sep―20 Heparin-induced Thrombocytopenia in Patients with Coronavirus Disease 2019: Systematic Review and Meta-analysis Noppacharn Uaprasert, Nuanrat Tangcheewinsirikul, Ponlapat Rojnuckarin, Rushad Patell, Jeffrey I. Zwicker, Thita Chiasakul
299 [GO] Blood Advances 2021―Sep―16 Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2; a prospective study Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, et al. (+8)
300 [GO] Blood 2021―Sep―06 COVID-19 as a potential trigger of complement-mediated atypical HUS. Carine El-Sissy, Antonin Saldman, Gilbert zanetta, Paula Vieira-Martins, Coralie Poulain, Raphaël Cauchois, et al. (+12)
301 [GO] Blood Advances 2021―Sep―02 American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate intensity anticoagulation in critically ill patients Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+41)
302 [GO] Blood Advances 2021―Aug―13 Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma C. Perry, E. Luttwak, R. Balaban, G. Shefer, M. M. Morales, A. Aharon, et al. (+10)
303 [GO] Blood Advances 2021―Aug―13 Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies Jennifer L. Crombie, Amy C. Sherman, Chi-An Cheng, Christine E. Ryan, Rebecca Zon, Michaël Desjardins, et al. (+13)
304 [GO] Blood 2021―Aug―02 Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy Binod Dhakal, Sameem M Abedin, Timothy S. Fenske, Saurabh Chhabra, Nathan Ledeboer, Parameswaran Hari, Mehdi Hamadani
305 [GO] Blood 2021―Jul―23 COVID-19 in patients with CLL: improved survival outcomes and update on management strategies Lindsey Elizabeth Roeker, Toby Andrew Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff, Matthew S. Davids, et al. (+45)
306 [GO] Blood 2021―Jul―23 Immune Thrombocytopenic Purpura after vaccination with COVID-19 Vaccine (ChAdOx1 nCov-19) Finn-Ole Paulsen, Christoph Schaefers, Florian Langer, Christian Frenzel, Ulrich Wenzel, Felicitas E. Hengel, et al. (+2)
307 [GO] Blood 2021―Jul―19 Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein Andreas Greinacher, Kathleen Selleng, Julia Mayerle, Raghavendra Palankar, Jan Wesche, Sven Reiche, et al. (+20)
308 [GO] Blood 2021―Jul―15 Thrombosis with COVID-19: kids get it too Cliff Takemoto
309 [GO] Blood Advances 2021―Jul―13 Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz
310 [GO] Blood 2021―Jul―01 Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies Paola Ghione, Juan J Gu, Kristopher Attwood, Pallawi Torka, Shipra Goel, Suchitra Sundaram, et al. (+16)
311 [GO] Blood Advances 2021―Jul―01 Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease Lana Mucalo, Amanda M. Brandow, Mahua Dasgupta, Sadie F. Mason, Pippa M. Simpson, Ashima Singh, et al. (+4)
312 [GO] The Hematologist 2021―Jun―22 Masking, Vaccination, and Research Needed to Protect Our Most Vulnerable Against COVID-19 Jane N. Winter, Martin S. Tallman
313 [GO] The Hematologist 2021―Jun―22 What Is the Price of Preventing COVID-19 Infection? Rare Thrombotic/Thrombocytopenic Events Reported After Vaccination Damon E. Houghton, Anand Padmanabhan
314 [GO] Blood Advances 2021―Jun―17 A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2 Anne Louise Tølbøll Sørensen, Magalie Rolland, Jacob Hartmann, Zitta Barrella Harboe, Casper Roed, Tomas Ø. Jensen, et al. (+13)
315 [GO] Blood 2021―Jun―10 Efficacy of COVID-19 vaccine in patients with CLL
316 [GO] Blood 2021―Jun―10 Vaccination against COVID-19: a challenge in CLL Barbara Eichhorst
317 [GO] Blood 2021―Jun―02 SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation by activation of acid sphingomyelinase Jue Wang, Usha R. Pendurthi, Guohua Yi, L. Vijaya Mohan Rao
318 [GO] Blood 2021―May―20 Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry Dimitrios Giannis, Steven L. Allen, James Tsang, Sarah Flint, Tamir Pinhasov, Stephanie Williams, et al. (+22)
319 [GO] Blood 2021―May―14 Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2 Thomas Thiele, Lena Ulm, Silva Holtfreter, Linda Schönborn, Sven Olaf Kuhn, Christian Scheer, et al. (+7)
320 [GO] Blood 2021―May―05 COVID-19 Vaccines Induce Severe Hemolysis in Paroxysmal Nocturnal Hemoglobinuria Gloria Frances Gerber, Xuan Yuan, Jia Yu, Benjamin A.Y. Cher, Evan M. Braunstein, Shruti Chaturvedi, Robert A. Brodsky
321 [GO] Blood 2021―May―05 A Flow cytometric assay to detect platelet activating antibodies in VITT after ChAdOx1 nCov-19 vaccination Stefan Handtke, Martina Wolff, Carlo Zaninetti, Jan Wesche, Linda Schönborn, Konstanze Aurich, et al. (+5)
322 [GO] Blood 2021―Apr―28 Prothrombotic immune thrombocytopenia after COVID-19 vaccine Andreas Tiede, Ulrich J Sachs, Andreas Czwalinna, Sonja Werwitzke, Rolf Bikker, Joachim K Krauss, et al. (+6)
323 [GO] Blood 2021―Apr―25 Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C Hilary Baker Whitworth, Sarah E Sartain, Riten Kumar, Katherine Armstrong, Lance Ballester, Marisol Betensky, et al. (+14)
324 [GO] Blood 2021―Apr―17 Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia Yair Herishanu, Irit Avivi, Anat Aharon, Gabi Shefer, Shai Levi, Yotam Bronstein, et al. (+7)
325 [GO] Blood 2021―Apr―17 Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose Evangelos Terpos, Ioannis P Trougakos, Maria Gavriatopoulou, Ioannis Papassotiriou, Aimilia D Sklirou, Ioannis Ntanasis-Stathopoulos, et al. (+4)
326 [GO] Blood Advances 2021―Apr―01 COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals Ashima Singh, Amanda M. Brandow, Julie A. Panepinto
327 [GO] Blood Advances 2021―Apr―01 Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation Chikara Ogimi, Hu Xie, Alpana Waghmare, Masumi Ueda Oshima, Kanwaldeep K. Mallhi, Keith R. Jerome, et al. (+3)
328 [GO] Blood 2021―Mar―18 Treon SP, Castillo JJ, Skarbnik AP, et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. Blood. 2020;135(21):1912-1915.
329 [GO] Blood Advances 2021―Mar―08 Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity Johan Courjon, Océane Dufies, Alexandre Robert, Laurent Bailly, Cédric Torre, David Chirio, et al. (+17)
330 [GO] Blood Advances 2021―Mar―03 The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A Shang-Chuen Wu, Connie M. Arthur, Jianmei Wang, Hans Verkerke, Cassandra D. Josephson, Daniel Kalman, et al. (+3)
331 [GO] Blood Advances 2021―Feb―26 A neutrophil activation signature predicts critical illness and mortality in COVID-19 Matthew L. Meizlish, Alexander B. Pine, Jason D. Bishai, George Goshua, Emily R. Nadelmann, Michael Simonov, et al. (+24)
332 [GO] Blood 2021―Feb―25 Another front in COVID-19’s perfect storm Shawn M. Jobe, Renren Wen
333 [GO] Blood Advances 2021―Feb―10 Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19 Chaja F. Jacobs, Eric Eldering, Arnon P. Kater
334 [GO] Blood Advances 2021―Feb―09 American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+39)
335 [GO] Blood Advances 2021―Feb―09 COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience Katie Maurer, Anna Saucier, Haesook T. Kim, Utkarsh Acharya, Clifton C. Mo, Julie Porter, et al. (+11)
336 [GO] Blood 2021―Feb―08 COVID-19 and Hematologic Malignancies: Single Institution Analysis Nwabundo Anusim, Melanie Smalley, Markie Sue Zimmer, Doyle Lang, Vishal Jindal, Hycienth O Ahaneku, et al. (+3)
337 [GO] Blood 2021―Feb―08 Association of Anticoagulant Use with COVID-19 Diagnosis Juraj Kavecansky, Jennifer R Dusendang, Jahan Tavakoli, Julie Schmittdiel, Gwendolyn Ho, Jodi Loyles, Ashok Pai
338 [GO] Blood 2021―Feb―08 Covid-19 Disease Is Not Associated with Venous Thromboembolism in a Cohort of Patients in Jeddah, Saudi Arabia Fatemah Kamel, Rania Magadmi, Sulafa Alqutub, Maha A. Badawi, Fatin Al-Sayes, Mazen Badawi, et al. (+2)
339 [GO] Blood 2021―Feb―08 Patient-Focused Benefits of at-Home Versus in-Clinic Administration of Cancer Therapy: New Considerations for the COVID-19 Era Karen E. Sandman, Timothy J. Bell
340 [GO] Blood 2021―Feb―08 Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN) Minoo Battiwalla, Carlos Bachier, Vikas Bhushan, Michael J. Eckrich, Alireza Eghtedar, Haydar Frangoul, et al. (+11)
341 [GO] Blood 2021―Feb―08 Delivering Systemic Anti-Cancer Treatment Via Another Route of Administration As an Option to Reduce Exposure to COVID-19 in Patients with Multiple Myeloma in the UK Holly Cranmer, Tanja Podkonjak, Eugene Benson, Jonathon Dabora, Graham H Jackson
342 [GO] Blood 2021―Feb―08 ABO Blood Type and Outcomes in a Diverse COVID-19 Infected Population Sonal Paul, Nisha Patel, Chathula Kumarasinghe, Neil Nimkar, Angelica Singh, Nivetha Vishnuvardhan, et al. (+10)
343 [GO] Blood 2021―Feb―08 Association of Blood Type on Clinical Outcomes in Black/African Americans Hospitalized for COVID-19 Infection Yan Cheng, Sharif Mohammed, Alexis Okoh, Ki (Steve) Lee, Corinne Raczek, Amin Krushna, et al. (+2)
344 [GO] Blood 2021―Feb―08 Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection Carlos A Lopez, David Chitty, Jeffrey Chi, Wasif Saif, Bradley Goldberg
345 [GO] Blood 2021―Feb―08 Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies Elizabeth Behrens, Anne Timmermann, Alexander Yerkan, Deborah A. Katz, Agne Paner, Melissa C. Larson, et al. (+9)
346 [GO] Blood 2021―Feb―08 Prediction of COVID-19 Mortality in Patients with Cancer Simon Mantha, Justin Jee, Gerald A. Soff, Melissa S. Pessin
347 [GO] Blood 2021―Feb―08 Clinical Impact of COVID-19 on Anticoagulation Management at the William S. Middleton Memorial Veterans Hospital Hannah Hecht, Allison B Riendeau, Jillian Kolasinski, Cheryl Ray, Moniba Nazeef
348 [GO] Blood 2021―Feb―08 Increased Productivity and Efficiency Among Cancer Center Clinical Trials Workforce during the COVID-19 Pandemic Kimberly C Jenkins, Emily C Zabor, Lindsey A. R. Mooney, Aaron T. Gerds, Kerry O'Hop, Makenzie Guy, et al. (+3)
349 [GO] Blood 2021―Feb―08 A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic Helen Cashman, Eleni Mayson, David Kliman, Sue Vachalec, Jennifer Bell, Sam Milliken, et al. (+4)
350 [GO] Blood 2021―Feb―08 Utilization of Telemedicine for Comprehensive Visits in Patients with Inherited Bleeding Disorders during the COVID-19 Pandemic Cassandra P Wang, Kelly Ann Bush, Rosalie Brooks, Katharine Farrow, Lizandra Gilsdorf, Fernanda Cortez, Courtney D Thornburg
351 [GO] Blood 2021―Feb―08 Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience Giamal Edin Gmati, Nadine Mabsut, Zainab Matar, Mona Alshami, Husam Shahata, Areej Alkhesaifi, et al. (+9)
352 [GO] Blood 2021―Feb―08 COVID-19 Pandemic Highlights Health Disparities in Latinos in San Diego Elisa Quiroz, David J Hermel, Samantha R Bagsic, Carrie L. Costantini, Anuj Mahindra, Alan Saven, et al. (+2)
353 [GO] Blood 2021―Feb―08 Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients Angelica D'Aiello, Sumaira Zareef, Kith Pradhan, Amanda Lombardo, Fariha Khatun, Jennat Mustafa, et al. (+39)
354 [GO] Blood 2021―Feb―08 Thrombotic Complications in COVID-19 Patients: Low Incidence of Thrombotic Complications Among Critically Ill COVID-19 Patients in Singapore Cheryl XQ Lim, Chuen Wen Tan, Bingwen Eugene Fan, Winnie Teo, Moon Ley Tung, Humaira Shafi, et al. (+21)
355 [GO] Blood 2021―Feb―08 COVID-19 Prognostic Score Utilizing Hematological and Inflammatory Markers to Determine Outcomes of Hospitalized Patients Amardeep Kalsi, Sana Irfan Khan, Asad Rehman, Neil Nimkar, Angelica Singh, Nivetha Vishnuvardhan, et al. (+11)
356 [GO] Blood 2021―Feb―08 Improvement in Clinic Efficiency, Patient Satisfaction, and Overcoming Unique Challenges in the Era of COVID-19 with Implementation of Subcutaneous Daratumumab in Patients with Multiple Myeloma (MM) and Light Chain (AL) Amyloidosis David Hughes, Radhika Jhaveri, Bhavesh Shah, Frances Blevins, Alexamil Rodriguez, Shayna Sarosiek, et al. (+3)
357 [GO] Blood 2021―Feb―08 Assessment of Hematologic and Coagulation Parameters As Predictive Value in COVID-19 with Unfavourable Evolution Viola Maria Popov, Lelia Iliescu, Marius Ioan Balea, Daniela Georgeta Georgescu, Mihaela Andreescu, Horia Bumbea, et al. (+21)
358 [GO] Blood 2021―Feb―08 Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, Richard McNally, Adrianne Kelly, Marco Romano, et al. (+5)
359 [GO] Blood 2021―Feb―08 Excellent Outcomes of Patients of Middle Eastern Ethnic Origin with Autologous Haemopoietic Stem Cell Transplantation and COVID-19: Does a Dampened Immune System Protect Against Severe COVID-19? Imran K Tailor, Syed Y Altaf, Nawal F Alshehry, Alaa M Alser, Mohammed Marei, Mansour Alfayez, et al. (+2)
360 [GO] Blood 2021―Feb―08 A Machine Learning Approach for the Differential Diagnosis between Sars-COV19 Infection and Influenza Viruses with Hematological Morphologic DATA (CELL MORPHOLOGIC DATA) Fernando Calvo Boyero, Sandra Gomez Gomez Rojas, Gloria Perez Segura, Ana Lopez Jimenez, Miguel Pedrera Jimenez, Gonzalo Carreño Gomez-Tarragona, et al. (+2)
361 [GO] Blood 2021―Feb―08 Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic Alberto Mussetti, Maria Queralt Salas Gay, Maria Condom, Maite Antonio, Cristian Ochoa, Iulia Ivan, et al. (+6)
362 [GO] Blood 2021―Feb―08 Critical Care Support Improves Outcome of Haematology Admissions: A Retrospective Analysis during Covid Pandemic from UK Richard Whitmill, Supratik Basu, Anandadeep Mandal, Ubon Usung, Arwa Babai, Mustafa Mohamed
363 [GO] Blood 2021―Feb―08 Perception and Psychological Help Seeking Behaviour Among Hematology Healthcare Workers during the COVID19 Pandemic in India Lakshmi Prabha, Kishore Kumar
364 [GO] Blood 2021―Feb―08 COVID-19 Associated Coagulopathy: Thrombosis, Hemorrhage and Mortality Rates with an Escalated-Thromboprophylaxis Strategy Molly Daughety, Thomas L. Ortel, Erin Frost, Andrew Morgan, Chester Kao, Joyce Hwang, et al. (+2)
365 [GO] Blood 2021―Feb―08 Edoxaban Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Hospitalized Patients with Atrial Fibrillation and COVID-19 Infection Pável E Olivera, Desiree Campoy, César A Velasquez, Katia Flores, Tania Canals, Erik A Johansson, et al. (+4)
366 [GO] Blood 2021―Feb―08 Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic Valentina Baez Sosa, Cathy Conry-Cantilena, Glenn Wortmann, Emily R Fischer, Brandon G Clark, Lorraine Wyne, Aarthi Shenoy
367 [GO] Blood 2021―Feb―08 Clonal Hematopoiesis and COVID-19 Severity in Cancer Patients Kelly L. Bolton, Michael Foote, Justin Jee, Anton Safonov, Ryan Ptashkin, Sean Devlin, et al. (+13)
368 [GO] Blood 2021―Feb―08 Myelodysplastic Syndromes (MDS) & COVID-19: Clinical Experience from the US Epicenter of the Pandemic Jonathan Feld, Erin P. Demakos, Rosalie Odchimar-Reissig, Douglas Tremblay, Saudia Alli, Darshanie Sewah, et al. (+2)
369 [GO] Blood 2021―Feb―08 Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia Simone Claudiani, Carolina Rosadas, Myra McClure, Maryam Khan, Richard S. Tedder, Andrew J. Innes, et al. (+2)
370 [GO] Blood 2021―Feb―08 COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study Guilherme Fleury Perini, Juan Alejandro Ospina Idarraga, Maria Alejandra Torres Viera, Brady E Beltran, Denisse A. Castro, Victoria Otero, et al. (+34)
371 [GO] Blood 2021―Feb―08 Incidence of Venous Thromboembolic Events in Hospitalized COVID-19 Patients: A Systematic Review Nicolas Galllastegui Crestani, Jenny Y Zhou, Annette von Drygalski, Timothy A Morris
372 [GO] Blood 2021―Feb―08 Sars-Cov-2 Spike Protein Induces Cellular Changes in Primitive and Mature Hematopoietic Cells James Ropa, Scott Cooper, Maegan L. Capitano, Hal E. Broxmeyer
373 [GO] Blood 2021―Feb―08 Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients Jeanne M. Palmer, Carolyn Mead-Harvey, Claire Harrison, Amylou C. Dueck, Ryan Eckert, Heidi E. Kosiorek, et al. (+25)
374 [GO] Blood 2021―Feb―08 Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care Perla R. Colunga Pedraza, Julia Esther Colunga Pedraza, Andres Gomez-De Leon, Mónica Bustillos Muñoz, Karen Lorena Osorno-Rodriguez, Jose Angel Hawing, et al. (+5)
375 [GO] Blood 2021―Feb―07 COVID-19 Infection in Patients with Paroxysmal Nocturnal Hemoglobinuria in Italy Wilma Barcellini, Bruno Fattizzo, Luisa Quattrocchi, Juri Alessandro Giannotta, Semra Aydin, Federica Barone, et al. (+6)
376 [GO] Blood 2021―Feb―07 Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic Andrea Nowlin, Kristina Lai, Alexander Maillis, Patricia Waters, Beatrice Gee, Peter A. Lane
377 [GO] Blood 2021―Feb―07 Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic Jennifer G. Davila, W. Beau Mitchell, Kerry A Morrone, Ellen J Silver, Caterina P Minniti, Henny H. Billett, et al. (+3)
378 [GO] Blood 2021―Feb―07 COVID-19: B-Cell Depletion and Sepsis Related Changes in Bone Marrow and Spleen Jana Ihlow, Ann-Christin von-Bruenneck, Edward Georg Michaelis, Selina Greuel, Verena Heynol, Annika Lehmann, et al. (+9)
379 [GO] Blood 2021―Feb―07 Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection Lauren E. Merz, Kavita Mistry, Revital Freedman, Katherine L Jolley, Hae Soo Park, David M. Dorfman, et al. (+2)
380 [GO] Blood 2021―Feb―07 Thrombosis and Risk Management in Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with Sars-CoV2 (PIMS-TS) Ho Pui Jeff Lam, Jayanthi Alamelu, James Brighouse, Owen Miller, Jonathan Lillie, Baba PD Inusa
381 [GO] Blood 2021―Feb―06 Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19 Hanny Al-Samkari, Fei Song, Elizabeth M. Van Cott, David J. Kuter, Rachel P. Rosovsky
382 [GO] Blood 2021―Feb―06 Filter Clotting with Continuous Renal Replacement Therapy in COVID-19 Rachel P. Rosovsky, Paul Endres, Soophia H Zhao, Scott Krinsky, Shananssa G Percy, Omer Kamal, et al. (+13)
383 [GO] Blood 2021―Feb―06 Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19 Spyridoula Vasileiou, Manik Kuvalekar, Aster Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, et al. (+7)
384 [GO] Blood 2021―Feb―06 Worldwide Examination of Patients with CLL Hospitalized for COVID-19 Lindsey E Roeker, Lydia Scarfo, Thomas Chatzikonstantinou, Pau Abrisqueta, Toby A. Eyre, Raul Cordoba, et al. (+147)
385 [GO] Blood 2021―Feb―06 Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19 Michael Roderick Cook, Kaitlyn C Dykes, Katherine White, Jaeil Ahn, Nathan Cobb, Catherine Lai
386 [GO] Blood 2021―Feb―06 Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis Samuel Rubinstein, Ryan C. Lynch, Aakash Desai, Catherine Stratton, Alokkumar Jha, Ziad Bakouny, et al. (+12)
387 [GO] Blood 2021―Feb―06 Clinical Course and Outcomes of Sickle Cell Disease Patients with COVID-19 at a New York Hospital Anita Mazloom, Neil Nimkar, Sonal Paul, Ayanna Baptiste
388 [GO] Blood 2021―Feb―06 COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study Delphine Rea, Michael J. Mauro, Jorge E. Cortes, Qian Jiang, Katia B Pagnano, Matilda Ongondi, et al. (+4)
389 [GO] Blood 2021―Feb―06 Critical Telehealth and Healthcare Utilization during COVID-19 in Sickle Cell Disease: CBO Reach in Understanding the Patient Experience Jennifer Fields, Mary Brown, Chanell Grismore, Yadira Badwan, Susan Claster, Diane J. Nugent
390 [GO] Blood 2021―Feb―06 The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives Ana I. Velazquez Manana, Urshila Durani, Robby Reynolds, Ashok Kumbamu, Devika G. Das, Martina C. Murphy, et al. (+3)
391 [GO] Blood 2021―Feb―06 Impact on Mental Health, Disease Management and Socioeconomic Modifications in Hematological Patients during COVID-19 Pandemia in Italy Marianna De Muro, Sergio Amadori, Nicolina Rita Ardu, Elisabetta Cerchiara, Paolo De Fabritiis, Pasquale Niscola, et al. (+5)
392 [GO] Blood 2021―Feb―06 Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic Gonzalo De Luna, Nicolas Lemonier, Alexis Aidan, Lea Bontemps, Manuel Hautefaye, Hadrien Diakonoff, et al. (+7)
393 [GO] Blood 2021―Feb―06 Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caretakers: Baseline Depression and COVID-19 Pandemic-Associated Psychosocial Stress in a Multi-Site Study Nancy S. Green, Deepa Manwani, Kim Smith-Whitley, Banu Aygun, Abena Appiah-Kubi, Arlene Smaldone
394 [GO] Blood 2021―Feb―06 Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry Roberta Demichelis, Martha Alvarado, Jule F Vasquez, Nancy Delgado, Cynthia Gómez, Karla Adriana Espinosa, et al. (+26)
395 [GO] Blood 2021―Feb―06 Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients Surbhi Warrior, Elizabeth Behrens, Joshua Thomas, Priya Rajakumar, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
396 [GO] Blood 2021―Feb―06 Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients Filip Ionescu, Girish B Nair, Ioana Petrescu, Anish S Konde, Markie Sue Zimmer, Nwabundo Anusim, et al. (+6)
397 [GO] Blood Advances 2021―Feb―06 Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge Fien A. von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Maria Magnusson, Nigel Mackman, et al. (+2)
398 [GO] Blood 2021―Feb―06 Hematologic Characteristics of Surviving Versus Non-Surviving COVID-19 Patients in Critical Care Units: Inner-City Hospital Experience, Detroit, MI Nino Balanchivadze, Raef Fadel, Jawad Sheqwara, Philip Kuriakose
399 [GO] Blood 2021―Feb―06 Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched Analysis George Goshua, Yiwen Liu, Matthew L. Meizlish, Rebecca Fine, Kejal Amin, Eric Chang, et al. (+9)
400 [GO] Blood 2021―Feb―06 The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility in COVID-19: A Retrospective Population Study of 3305 Patients Waleed Alduaij, Sarah Al-Youha, Ahmad Al-Serri, Sulaiman Almazeedi, Mohannad Al-Haddad, Mohammad H Jamal, Salman Al-Sabah
401 [GO] Blood 2021―Feb―06 Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients Abi Vijenthira, Inna Gong, Thomas A Fox, Stephen Booth, Gordon Cook, Bruno Fattizzo, et al. (+13)
402 [GO] Blood 2021―Feb―06 Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus Nicoletta Di Maio, Giovanna Russo, Susanna Barella, Gian Luca Forni, Raffaella Colombatti, Lucia Notarangelo, et al. (+38)
403 [GO] Blood 2021―Feb―06 Leveraging Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest: Expanding Provider Education during a Pandemic Lisa M Shook, Christina Bennett Farrell, Cami Mosley, Lori E Crosby, Charles T. Quinn
404 [GO] Blood Advances 2021―Feb―02 Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 Erica Villa, Rosina Critelli, Simone Lasagni, Alessandra Melegari, Angela Curatolo, Ciro Celsa, et al. (+28)
405 [GO] Blood Advances 2021―Jan―29 Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19 Christophe Guervilly, Amandine Bonifay, Stephane Burtey, Florence Sabatier, Raphaël Cauchois, Evelyne Abdili, et al. (+10)
406 [GO] Blood Advances 2021―Jan―29 Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19 Younes Zaid, Fadila Guessous, Florian Puhm, Wail Elhamdani, Lamyae Chentoufi, Andrew Conway Morris, et al. (+4)
407 [GO] Blood 2021―Jan―14 Vaccinations in CLL: implications for COVID-19 Mazyar Shadman, Chaitra Ujjani
408 [GO] Blood Advances 2021―Jan―13 Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection Caterina P. Minniti, Ahmar U. Zaidi, Mehdi Nouraie, Deepa Manwani, Gary D. Crouch, Andrew S. Crouch, et al. (+8)
409 [GO] Blood 2020―Dec―23 Antibody-induced procoagulant platelets in severe COVID-19 infection Karina Althaus, Irene Marini, Jan Zlamal, Lisann Pelzl, Anurag Singh, Helene Häberle, et al. (+11)
410 [GO] Blood 2020―Dec―19 Severe transient pancytopenia with dyserythropoiesis and dysmegakaryopoiesis in COVID-19-associated MIS-C Rachel Mariani, Huifei Liu
411 [GO] Blood 2020―Dec―19 Expanding the toolbox to combat a pandemic Susan E. Prockop
412 [GO] Blood Advances 2020―Dec―18 A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies Deborah M. Siegal, Geoffrey D. Barnes, Nicole J. Langlois, Adrienne Lee, Saskia Middeldorp, Leslie Skeith, et al. (+2)
413 [GO] Blood Advances 2020―Dec―17 Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up Richard Salisbury, Valentina Iotchkova, Sarah Jaafar, Joshua Morton, Gavinda Sangha, Akshay Shah, et al. (+3)
414 [GO] Blood Advances 2020―Dec―09 Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations Caroline Diorio, Kevin O. McNerney, Michele Lambert, Michele Paessler, Elizabeth M. Anderson, Sarah E. Henrickson, et al. (+22)
415 [GO] Blood Advances 2020―Dec―05 Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub William A. Wood, Donna S. Neuberg, J. Colton Thompson, Martin S. Tallman, Mikkael A. Sekeres, Laurie H. Sehn, et al. (+8)
416 [GO] Blood Advances 2020―Dec―05 Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients Susanne Ghandili, Susanne Pfefferle, Kevin Roedl, Piet Sonnemann, Panagiotis Karagiannis, Olaf Boenisch, et al. (+11)
417 [GO] Blood 2020―Dec―03 COVID-19, plasma, and hypogammaglobulinemia Michael F. Murphy, Sunny Dzik
418 [GO] Blood 2020―Dec―03 Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset Josée Perreault, Tony Tremblay, Marie-Josée Fournier, Mathieu Drouin, Guillaume Beaudoin-Bussières, Jérémie Prévost, et al. (+4)
419 [GO] Blood 2020―Nov―17 How should we use convalescent plasma therapies for COVID-19? Erica Michelle Wood, Lise J Estcourt, Zoe McQuilten
420 [GO] Blood 2020―Nov―06 Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society Dataset Ajai Chari, Mehmet Kemal Samur, Joaquin Martinez-Lopez, Gordon Cook, Noa Biran, Kwee L. Yong, et al. (+19)
421 [GO] Blood 2020―Nov―05 COVID-19-induced atypical pulmonary lymphocytes Véronique Vergé, Ranya Soufan
422 [GO] Blood 2020―Nov―04 Coagulation Dysfunction and Hematological Changes in 633 Patients with COVID-19 Mo Yang, Huixia Deng, Liuming Yang, Liang Li, Jieyu Ye, Yucai Cheng, et al. (+3)
423 [GO] Blood 2020―Nov―04 Thrombotic Complications in a Canadian Population of Critically Ill Patients with COVID-19 Simard Camille, Maral Koolian, Diana Escobar, Mark Blostein, Jed Lipes, Adelina Teona Avram, et al. (+4)
424 [GO] Blood 2020―Nov―04 Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19 Grigoris Gerotziafas, Patrick Van Dreden, Loula Papageorgiou, Theodoros N Sergentanis, Meletios-Athanasios Dimopoulos, Ismail Elalamy
425 [GO] Blood 2020―Nov―04 The Role of D-Dimer for Optimal Thromboprophylaxis Strategy in Patients with COVID-19 Lantarima Bhoopat, Anastasia Martynova, April Choi, Pattharawin Pattharanitima, Semi Han, Senxi Du, et al. (+5)
426 [GO] Blood 2020―Nov―04 Thrombosis and Mortality in Pregnant Patients with COVID-19 Elizabeth Behrens, Surbhi Warrior, Joshua Thomas, Xavier Pombar, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
427 [GO] Blood 2020―Nov―04 COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19 Isaac Chambers, Sanjana Dayal, Patrick Ten Eyck, Alicia Eustes, Grerk Sutamtewagul, Lori Rosenstein, et al. (+3)
428 [GO] Blood 2020―Nov―04 The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19 Rodolfo Jiménez-Soto, Mercedes Aguilar-Soto, Roberta Demichelis
429 [GO] Blood 2020―Nov―04 Incidence of Vascular Thromboembolic Events in Outpatients with Mild COVID-19 Harish Eswaran, Jamie Jarmul, Amy Shaheen, David Meaux, Tristan Long, Derek Saccoccio, Stephan Moll
430 [GO] Blood 2020―Nov―04 Mild Anemia As a Single Independent Predictor of Mortality in Patients with COVID-19 Douglas Tremblay, Joseph Rapp, Naomi Alpert, William Lieberman-Cribbin, John Mascarenhas, Emanuela Taioli, Saghi Ghaffari
431 [GO] Blood 2020―Nov―04 Heparin Induced Thrombocytopenia in Patients with COVID-19 Surbhi Warrior, Elizabeth Behrens, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
432 [GO] Blood 2020―Nov―04 Venous Thromboembolic Disease in Children Associated with COVID-19 Shalu Narang, Kavita Morparia, Prachi Sharma
433 [GO] Blood 2020―Nov―04 Immune Thrombocytopenia Associated with COVID-19 - Case Series Ramil Fatkhullin, Vasily Shuvaev
434 [GO] Blood 2020―Nov―04 Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study Patrick Van Dreden, Guillaume Voiriot, Alexandre Alabbadi, Ismail Elalamy, Loula Papageorgiou, Hélène Cost, et al. (+4)
435 [GO] Blood 2020―Nov―04 Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study Alienor Xhaard, Constance Xhaard, Maud D'Aveni, Hélène Salvator, Marie-Laure Chabi-Charvillat, Tereza Coman, et al. (+13)
436 [GO] Blood 2020―Nov―04 Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Ang Li, Nicole M. Kuderer, Jeremy L. Warner, Aakash Desai, Dimpy P. Shah, Julie Fu, et al. (+25)
437 [GO] Blood 2020―Nov―04 Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy Ruimin Hong, Houli Zhao, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, et al. (+2)
438 [GO] Blood 2020―Nov―04 COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH) Per Ljungman, Rafael De La Camara, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, Yves Beguin, et al. (+32)
439 [GO] Blood 2020―Nov―04 Circulating Histone Levels Correlate with the Severity of COVID-19 and the Extent of Coagulation Activation and Inflammation Rebecca Jane Shaw, James Austin, Joseph Taylor, Tina Dutt, Guozheng Wang, Simon Timothy Abrams, Cheng Hock Toh
440 [GO] Blood 2020―Nov―04 COVID-19 Associated Coagulopathy: A Comprehensive Assessment of the Coagulation Profile in Critically and Non-Critically Ill Patients Reyes María Martín-Rojas, Maite Chasco, Sara Casanova, Valeria Estefanía Delgado-Pinos, Gloria Perez-Rus, Patricia Duque, et al. (+3)
441 [GO] Blood 2020―Nov―04 Children and Young Adults Admitted to a NYC Children's Hospital Had a Similar Rate of Severe COVID-19 Coagulopathy As That Reported in Older Adults William Beau Mitchell, Jennifer G. Davila, Janine Keenan, Jenai Jackson, Adit Tal, Kerry A Morrone, et al. (+3)
442 [GO] Blood 2020―Nov―04 Newly Diagnosed Acute Lymphoblastic Leukemia in a Child with COVID-19 Complicated By MIS-C: A Case Report from Kuwait Fatemah Al-Haddad, Abdullah Ali, Danah Al-Sharrah, Suha Atyani, Hadeel Saleh, Ali M.A. Mullah-Ali
443 [GO] Blood 2020―Nov―04 COVID-19 Convalescent Plasma Decreased Oxygen Requirement and Hospital Stay in COVID-19 Hospitalized Patients Including Those with Hematological Malignancies: A Report of 16 Patients Moayed Ibrahim, Priya Pal, Alex Niu, Kevin Zwezdaryk, Elise Tatje, Leta Ko, et al. (+19)
444 [GO] Blood 2020―Nov―04 Whimsical (Waldenstrom's Macroglobulinemia Study Involving CArt-wheeL): A Global Patient-Derived Data Registry Capturing Treatment, Quality of Life and COVID-19 Data Ibrahim Tohidi-Esfahani, Andrew Warden, Elena Malunis, Peter Liburdi deNardis, Javier Haurat, Marita Black, et al. (+9)
445 [GO] Blood 2020―Nov―04 Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis Cong Zhang, Jialan Shi, Changjun WU, Chunxu Wang, Xinyi Zhao, Jinming Zhang, et al. (+9)
446 [GO] Blood 2020―Nov―04 The ACE2 Receptor for COVID-19 Entry Is Expressed on the Surface of Hematopoietic Stem/Progenitor Cells and Endothelial Progenitors As Well As Their Precursor Cells and Becomes Activated in Nlrp3 Inflammasome-Dependent Manner By Virus Spike Protein - a Potential Pathway Leading to a "Cytokine Storm" Magdalena Kucia, Kamila Bujko, Andrzej Ciechanowicz, Monika Cymer, Katarzyna Sielatycka, Janina Ratajczak, Mariusz Z Ratajczak
447 [GO] Blood 2020―Nov―04 COVID-19 Impact on Lymphoma Patients' Clinical Outcomes - an Observational Cohort Study Andrew Ip, Anthony Mato, Jordan Intrator, Nicholas P Howard, Alessandra Petrillo, Rosalba Vicioso, et al. (+6)
448 [GO] Blood 2020―Nov―04 COVID-19 in Chronic Myeloid Leukemia Patients - Brazilian Experience Katia B Pagnano, Ana Carolina Mourão Toreli, Leila Martins Perobelli, Acy TS Quixada, Fernanda S Seguro, Israel Bendit, et al. (+19)
449 [GO] Blood 2020―Nov―04 Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients Clarisse MARTINS Machado, Mariana Nassif Kerbauy, Iago Colturato, Leonardo Javier Arcuri, Ana Cláudia Ferrari dos Santos, Fernanda Rodrigues Silva, et al. (+5)
450 [GO] Blood 2020―Nov―04 COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience Lindsay Wilde, Adam F. Binder, Matthew Carabasi, Joanne Filicko-O'Hara, John L. Wagner, Onder Alpdogan, et al. (+12)
451 [GO] Blood 2020―Nov―04 COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality Alex Niu, Bo Ning, Francisco Socola, Hana Safah, Tim Reynolds, Moayed Ibrahim, et al. (+6)
452 [GO] Blood 2020―Nov―04 COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting Saikrishna Gadde, Nikhil Manjunath, Ambuga Badari, John T. Cole, Rula Saeed
453 [GO] Blood 2020―Nov―04 Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry Olga A. Gavrilina, Kristina Zakurdaeva, Vladimir I. Vorobyev, Anastasia N. Vasileva, Lev S. Butaev, Alena Sukhareva, et al. (+15)
454 [GO] Blood 2020―Nov―04 Hepatobiliary Manifistations of COVID-19 in Sickle Cell Disease: A Case Report Badria M. Alghamdi, Ohoud F. Kashari
455 [GO] Blood 2020―Nov―04 Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups Josep-Maria Ribera, Mireia Morgades, Rosa Coll, Jose Luis Lopez Lorenzo, Pau Montesinos, Rosario Varela, et al. (+15)
456 [GO] Blood 2020―Nov―04 Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection Lana Mucalo, Amanda M. Brandow, Sadie F. Mason, Ashima Singh, Bradley W. Taylor, Katherine J. Woods, et al. (+2)
457 [GO] Blood 2020―Nov―04 Elderly Hemopoietic and Inflammatory Signature for Life-Threatening COVID-19 Infection Jesus Romero, Jorge Mazzini, Sarvari Venkata Yellapragada, Iberia R. Sosa, Gustavo A. Rivero
458 [GO] Blood 2020―Nov―04 Autoimmune Hemolytic Anemia As Initial Presentation of COVID-19 Infection Gregorio Campos-Cabrera, Esther Mendez-Garcia, Maria Mora-Torres, Salvador Campos-Cabrera, Virgina Campos-Cabrera, Gabriel Garcia-Rubio, Jose-Luis Campos-Villagomez
459 [GO] Blood 2020―Nov―04 Atypical Presentation of COVID-19 Infection Cory Mellon, Salma Ferouz, Tariq Mubarak, Isoken Koko
460 [GO] Blood 2020―Nov―04 Evaluation of Soluble Fibrin Monomer Complex in Patients with Sars-Cov-2 COVID-19 Infection Meera Sridharan, Aneel A. Ashrani, Dong Chen, Nahla M. Heikal, Ariela L. Marshall, Rajiv K. Pruthi
461 [GO] Blood 2020―Nov―04 Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis? Félix Gibrant Marquez, Santiago Riviello-Goya, Angel Gabriel Vargas Ruiz, Edgar Ortíz Brizuela, Fernando Gil López, Alfredo Gutierrez Marín, et al. (+4)
462 [GO] Blood 2020―Nov―04 Outcomes of COVID-19 Infection in Patients Receiving Ruxolitinib and Hypomethylating Agent Therapy Daniel I. Nathan, Douglas Tremblay, Santiago Thibaud, John Mascarenhas, Janice L. Gabrilove
463 [GO] Blood 2020―Nov―04 ABO/Rh Blood Group and COVID-19 Infection Severity David J Hermel, Elisa Quiroz, Samantha R Bagsic, Carrie L. Costantini, Alan Saven, James R. Mason, et al. (+3)
464 [GO] Blood 2020―Nov―04 Outcomes of Patients with Hematologic Malignancies and COVID-19 Infection: A Report from the ASH Research Collaborative Data Hub William A. Wood, Donna S. Neuberg, John Colton Thompson, Martin S. Tallman, Mikkael A. Sekeres, Laurie H. Sehn, et al. (+8)
465 [GO] Blood 2020―Nov―04 Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience Sarah Sewaralthahab, Hedy Smith
466 [GO] Blood 2020―Nov―04 Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina Laurence Noisette, Mamatha Mandava, Mathew Gregoski, Shayla Bergmann
467 [GO] Blood 2020―Nov―04 The Elevation of LIVER Enzymes in Patients with Atrial Fibrillation and COVID-19 Is a Marker of Bad Evolution and Mortality Juan Jose Cerezo Manchado, Pável E Olivera, María Dolores Lopez Abellan, Desiree Campoy Castaño, César A Velasquez, Carlos Rodriguez Rojas, et al. (+7)
468 [GO] Blood 2020―Nov―04 Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment Urshila Durani, Ana I. Velazquez Manana, Jori May, Marquita Nelson, Ze Zheng, Anurekha Gollapudi, et al. (+11)
469 [GO] Blood 2020―Nov―04 Impact of a National Lockdown for COVID-19 on Morbidity and Mortality Among Children with Sickle Cell Anaemia at a Tertiary Care Hospital in Uganda Ruth Namazzi, Robert Opoka, Andrea L Conroy, Dibyadyuti Datta, Micheal Goings, Chandy C. John
470 [GO] Blood 2020―Nov―04 COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait Ashima Singh, Amanda M. Brandow, Julie Panepinto
471 [GO] Blood 2020―Nov―04 Hematology Consultations during the COVID-19 Pandemic at a University Medical Center Daniel C Choi, Madhav Seshadri, Maria T De Sancho
472 [GO] Blood 2020―Nov―04 Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care Blake T. Langlais, Carolyn Mead-Harvey, Heidi E. Kosiorek, Gina L. Mazza, Ruben Mesa, Jeanne M. Palmer, Amylou C. Dueck
473 [GO] Blood 2020―Nov―04 A Survey of Survival Status of 601 Hemophilia Patients in Guangdong Region during COVID-19 Pandemic: Investigation and Implications Lei Meng, Jing Sun, Yufang Xun, Huiping Li, Zhuqin Liu, Xiaoqin Feng, Xuan Zhou
474 [GO] Blood 2020―Nov―04 The Challenge of Recruiting Convalescent Plasma Donors during the COVID-19 Pandemic: Preliminary Results from a Single Center in Midwest Brazil Maria do Rosario Ferraz Roberti, Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Maria Cunha Ribeiro Morelli, et al. (+5)
475 [GO] Blood 2020―Nov―04 Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study Nina Khanna, Maja Weisser, Anemone Hedstueck, Sarah Tschudin Sutter, Sandra Roesch, Manuel Battegay, et al. (+15)
476 [GO] Blood 2020―Nov―04 A National Collaborative Multicenter Phase II Study for Potential Safety Efficacy of Convalescent Plasma to Treat Severe COVID-19 Patients Hani Al Hashmi, Deia Alawami, Syed Ziauddin A Zaidi, Nawal F Alshehry, Hazza A. Alzahrani, Abdul Rehman Z Zaidi, et al. (+15)
477 [GO] Blood 2020―Nov―04 Correlation between ABO Blood Groups and Disease Severity and Mortality in Hospitalized COVID-19 Patients Aula Ramo, Harshita Mehrotra, Ifeoma Onwubiko, Jawad Sheqwara, Zaher K. Otrock
478 [GO] Blood 2020―Nov―04 Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients Gwendolyn Ho, Jennifer R Dusendang, Julie Schmittdiel, Juraj Kavecansky, Jahan Tavakoli, Ashok Pai
479 [GO] Blood 2020―Nov―04 Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients Farah Ashraf, Anita Mazloom, Neil Nimkar, Nisha Patel, Amardeep Kalsi, Angelica Singh, et al. (+10)
480 [GO] Blood 2020―Nov―04 Hemorrhage Is a Major Cause of Blood Transfusion in COVID-19 Patients Cristina Sanz, Anabel Faundez, Anna García Carulla, Marta Rodriguez Aliberas, Anny Coromoto, Arturo Pereira
481 [GO] Blood 2020―Nov―04 Impact of Blood Group Type on Severity of Disease in COVID-19 Patients Shivani Rao, Surbhi Warrior, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
482 [GO] Blood 2020―Nov―04 Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients Eleni Gavriilaki, Styliani Kokoris, Tasoula Touloumenidou, Evdoxia Koravou, Maria Koutra, Vassiliki Karali, et al. (+16)
483 [GO] Blood 2020―Nov―04 The Correlation between Absolute Lymphocyte Counts and Clinical Outcomes in COVID-19 Patients Mayer Goldberg, Madhumati Kalavar, Joseph Giovanetti
484 [GO] Blood 2020―Nov―04 Thrombocytopenia Associated with Increase in Disease Severity and Mortality in COVID-19 Patients Ranjit Banwait, Aya Marachi, Uma G. Iyer
485 [GO] Blood 2020―Nov―04 The Potential Role of Therapeutic Dose of Low Molecular Weight Heparin (LWMH) to Attenuate Hyper-Inflammatory State in Hospitalized COVID-19 Patients Mohsin Sheraz Mughal, Ikwinder Preet Kaur, Ali R. Jaffery, Chang Wang, Muhammad Asif, Anthony J. Ricca, et al. (+3)
486 [GO] Blood 2020―Nov―04 Extensive Characterization of the Hemostatic Derangement Occurring in COVID-19 Patients Admitted to the Bergamo Hospital Patricia Gomez-Rosas, Marina Marchetti, Eleonora Sanga, Sara Gamba, Cristina Verzeroli, Laura Russo, et al. (+7)
487 [GO] Blood 2020―Nov―04 Thrombotic Events in COVID-19 Patients and Its Comparison with Other Non-Sars-Cov-2 Respiratory Viruses Jing Yuan Tan, Chuen Wen Tan, Wan Hui Wong, Edwin Philip Conceicao, Ian Matthias Ng, May Anne Cheong, et al. (+3)
488 [GO] Blood 2020―Nov―04 Incidence of Thrombosis and Associated Risk Factors in Hospitalized COVID-19 Patients in a New York City Hospital System Poy P. Theprungsirikul, Sunil E. Saith
489 [GO] Blood 2020―Nov―04 Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry Dimitrios Giannis, Steven L. Allen, Anne Davidson, Galina S. Marder, Sarah Flint, David Garrett, et al. (+8)
490 [GO] Blood 2020―Nov―04 Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation Rich Kodama, Amardeep Kalsi, Angelica Singh, Nivetha Vishnuvardhan, Neil Nimkar, Sonal Paul, et al. (+10)
491 [GO] Blood 2020―Nov―04 Association between ROTEM Hypercoagulable Profile and Outcome in a Cohort of Severely Ill COVID-19 Patients Under Mechanical Ventilation Damian Ratano, Caragata Rebecca, Eddy Fan, Ewan C Goligher, Rita Selby, Niall D Ferguson, et al. (+2)
492 [GO] Blood 2020―Nov―04 Immunologic Characterization of Coronavirus Disease 2019 (COVID-19) Patients with Hematological Cancer: Biologic and Clinical Significance Catarina Maia, Esperanza Martín-Sánchez, Juan José Garcés, Ascensión López-Diaz de Cerio, Susana Inogés, Manuel Landecho, et al. (+16)
493 [GO] Blood 2020―Nov―04 Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease Nwabundo Anusim, Ruby Gupta, Hycienth O Ahaneku, Candace Franklin, Savitha Balaraman, Marianne Terese Huben, Ishmael Jaiyesimi
494 [GO] Blood 2020―Nov―04 Use of Convalescent Plasma in COVID-19 Patients: Guayaquil, Ecuador Experience. Carlos Plaza, Brener Sabando, Yaira Loor Morán, Maria Alejandra Posligua, Luis Layedra, Jorge William Oliveros-Alvear
495 [GO] Blood 2020―Nov―04 Anticoagulation Management and Outcomes in Covid-19 Patients:a Multi-Center Retrospective Cohort Study Jasmeet Kaur, Anupam A Sule, Tracy Koehler, Geetha Krishnamoorthy, Jennifer DeLongpre
496 [GO] Blood 2020―Nov―04 Higher Tissue Factor (TF) Expression in the Lungs of COVID-19 Pneumonia Patients Than Patients with Acute Respiratory Distress Syndrome: Association with Thrombi Formation Sandeep Subrahmanian, Alain Borczuk, Steven P. Salvatore, Jeffrey Laurence, Jasimuddin Ahamed
497 [GO] Blood 2020―Nov―04 Clinical Trial to Evaluate an Approved ITP Therapy Targeting Spleen Tyrosine Kinase (SYK) for Prevention and Treatment of COVID-19 Related Complications Wolfgang Dummer, Vadim V. Markovtsov, Sandra Tong, Esteban Masuda
498 [GO] Blood 2020―Nov―04 Atypical Peripheral Blood Cell Morphology in COVID-19 (Sars-CoV-2) Patients from Mount Sinai Health System in New York City Christian Salib, Pallavi Khattar, Jinjun Cheng, Julie Teruya-Feldstein
499 [GO] Blood 2020―Nov―04 Does Thrombocytopenia Truly Correlate with COVID-19 Severity? Caroline Hana, Samar Aboulenain, Nakeya Dewaswala, Vijay Narendran
500 [GO] Blood 2020―Nov―04 Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease Mahmoud A.Z. Abdelaal, Dyala Abdelrahman, Mahir Cengiz, Hakan Yavuzer, Serap Yavuzer, Ivy Bien, et al. (+9)
501 [GO] Blood 2020―Nov―04 Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease Mari Thomas, Nishkantha Arulkumaran, David Brearley, Ferras Alwan, Deepak Singh, Michael P Lunn, et al. (+8)
502 [GO] Blood 2020―Nov―04 COVID-19 Thrombosis: Understanding the Negative Predictive Value in a Pandemic Talat Almukhtar, Julio Hajdenberg, Gurjot Garcha
503 [GO] Blood 2020―Nov―04 Serological Prevalence of Sars-Cov-2 Infection Among Chronic Myeloid Leukemia Patients Undergoing Tyrosine Kinase Inhibitor Treatment in Italy (COVID-19-HEM Study) Massimiliano Bonifacio, Gianni Binotto, Mario Tiribelli, Maria Cristina Miggiano, Malgorzata Monika Trawinska, Luigi Scaffidi, et al. (+14)
504 [GO] Blood 2020―Nov―04 Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty Ana Belen Moreno-Castaño, Sara Fernandez, Marta Palomo, Patricia Molina, Julia Martinez-Sanchez, Sergi Torramade-Moix, et al. (+12)
505 [GO] Blood 2020―Nov―04 Outcomes of Patients of Eastern Mediterranean Region with Lymphoma and COVID-19.Does Recent Chemo Immunotherapy Have a Role on Severity? Imran K Tailor, Nawal F Alshehry, Kamran Sabir, Abdul Rehman Z Zaidi, Mohammed Marei, Ibraheem Motabi, et al. (+3)
506 [GO] Blood 2020―Nov―04 CD28 Expression Distinguishes Plasma Cell Fate in Pediatric Patients Suffering from COVID-19/Kawasaki's Disease Vs MIS-C Adam Utley, Kelvin P. Lee, Mark Hicar
507 [GO] Blood 2020―Nov―04 VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study Daria V Madeeva, Jana Christian, George Goshua, Hyung J. Chun, Alfred Ian Lee, Alexander B Pine
508 [GO] Blood 2020―Nov―04 Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study Mark Crowther, David A. Garcia, Jason Hill, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig
509 [GO] Blood 2020―Nov―04 Successful Outcomes of Children Simultaneously Diagnosed with Acute Myeloid Leukemia and Covid-19: The Role of a Mild Chemotherapeutic Induction Regimen Mecneide Mendes Lins, Juliana Teixeira Costa, Alayde Vieira Wanderley, Adriana Seber, Cinthya Rocha, Luciana Nunes Silva, et al. (+4)
510 [GO] Blood 2020―Nov―04 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Hematologic Patients: Experience at the Hospital Attending More Patients in Spain Alba Cabirta, Macarena Izuzquiza, Isabel Ruiz-Camps, David Valcarcel, Eva Catala, M Moraima Jimenez, et al. (+11)
511 [GO] Blood 2020―Nov―04 Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience Sabrina L. Browning, Michael Gormally, Neima Briggs, Muyi Li, Alan Zakko, Maudry Laurent-Rolle, et al. (+11)
512 [GO] Blood 2020―Nov―04 Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2 Fernando Pérez-Jacobo, Luis Villela Villela, Edgar Velásquez-Vega, Jesús Hernández, Melani Otañez, Mónica Arellano-Mendoza, et al. (+23)
513 [GO] Blood 2020―Nov―04 Antibody Response Against Sars-Cov-2 in Convalescent Plasma Donors: Preliminary Results from a Single Center in Midwest Brazil Maria do Rosario Ferraz Roberti, Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Francielle Barreto Machado Candido, et al. (+4)
514 [GO] Blood 2020―Nov―04 Longitudinal Serological Response to Sars-COV-2 in Patients Affected By Hematologic Diseases Chiara Cattaneo, Valeria Cancelli, Chiara Pagani, Alessandra Tucci, Giuseppe Rossi, Luisa Imberti, et al. (+6)
515 [GO] Blood 2020―Nov―04 Detailed Immunophenotypic Profiling of Peripheral Blood Immune Cells in Patients with Hematologic Malignancies after Sars-Cov-2 Infection Forat Lutfi, Jonathan Siglin, Gabriela Sanchez-Petitto, Ali Bukhari, David Gottlieb, Dong Won Kim, et al. (+8)
516 [GO] Blood 2020―Nov―04 Sars-Cov-2 Infection and Systemic Light Chain Amyloidosis: The International Society of Amyloidosis' Survey Paolo Milani, Vaishali Sanchorawala, Ramon Lecumberri, Sunil Saith, Mathew S. Maurer, M. Teresa Cibeira, et al. (+3)
517 [GO] Blood 2020―Nov―04 Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry Pilar Martínez, Tomás Palanques Pastor, Jose Luiz Lopez Lorenzo, Javier Cornago Navascués, Gabriela Rodriguez-Macías, Isabel Cano, et al. (+36)
518 [GO] Blood 2020―Nov―04 Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group Rebeca Bailén, Mi Kwon, Beatriz Aguado, Rafael F. Duarte, Maria Calbacho, Anabelle Chinea, et al. (+12)
519 [GO] Blood 2020―Nov―04 Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group Jose M. Moraleda, Carmelo Carlo-Stella, David Garcia-Bernal, Ruben Jara Rubio, Enriqueta Andreu, Eleonora Calabretta, et al. (+18)
520 [GO] Blood 2020―Nov―04 Inflammation Drives Coagulopathies in Sars-Cov-2 Patients Martha MS Sim, Meenakshi Banerjee, Melissa Hollifield, Hammodah Alfar, Xian Li, Alice Thornton, et al. (+9)
521 [GO] Blood 2020―Nov―04 Evidence of Microangiopathy in Children with Sars-Cov-2 Regardless of Clinical Presentation Caroline Diorio, Kevin O McNerney, Michele P. Lambert, Michele Paessler, Julie Chase, Kandace Gollomp, et al. (+18)
522 [GO] Blood 2020―Nov―04 Impaired Sars-Cov-2 Specific Antibody Responses in Patients Treated with Anti-CD20 Antibodies Alessandra Sottini, Luisa Imberti, Simone Paghera, Vanessa Previcini, Chiara Cattaneo, Eugenia Quiros-Roldan, et al. (+7)
523 [GO] Blood 2020―Nov―04 Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings Mansi R Shah, Imraan Jan, Jeremy Johns, Kuldip Singh, Pallavi Kumar, Norma Belarmino, et al. (+7)
524 [GO] Blood 2020―Nov―04 Real World Outcomes of Sars-Cov-2 Thrombosis Rates across Three University Health Systems in the Chicago Metropolitan Area Stephanie Berg, Seo-Hyun Kim, Sonam Patel, Priya Rajakumar, Elizabeth Jane Elliott, Candice Schwartz, et al. (+32)
525 [GO] Blood 2020―Nov―04 Analysis of Sars-Cov-2-Associated Proteins Identify Tank-Binding Kinase-1 As an Immunotherapeutic Target in Multiple Myeloma Arghya Ray, Ting DU, Krishan Chauhan, Yan Song, Dharminder Chauhan, Kenneth Anderson
526 [GO] Blood 2020―Nov―04 Outcomes in Patients with Hematologic Malignancies Infected with Sars-Cov-2: The Northwestern University Experience Carlos Galvez, Imran Nizamuddin, Emily Tuchman, Peter Doukas, Neha Reddy, Jessica K. Altman, et al. (+15)
527 [GO] Blood 2020―Nov―04 Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study Cristina De Ramón, Jose Angel Hernandez-Rivas, Jose Antonio Rodríguez García, Enrique M. Ocio, María Teresa Gómez-Casares, Javier López Jiménez, et al. (+13)
528 [GO] Blood 2020―Nov―04 How We Did Bone Marrow Transplants amidst the COVID19 Pandemic Kishore Kumar, Durai Prabhu, Dharani Devi, Dilshada Pulikkal, Joshua Daniel, Chezhian Subash
529 [GO] Blood 2020―Nov―04 Impact of the COVID19 Pandemic on Admissions and Emergency Department Visits of Adults with Sickle Cell Disease Alice J. Cohen
530 [GO] Blood 2020―Nov―04 Maximising Capacity and Saving Cost in an Outpatient Chemotherapy Centre during a Pandemic: A Quality Improvement Project Ednajoy Ngo, Cheng Ean Chee, Melinda Khoo, Yee Mei Lee, Belinda Tan, Yen-Lin Chee, Wei-Ying Jen
531 [GO] Blood 2020―Nov―04 Caring for Patients with Sickle Cell Disease during a Pandemic: Continuing to Provide Automated Red Blood Cell Exchange Transfusions in Difficult Times Richard Curtis Godby, Ashton Kornbrust, Denis Noubouossie, Jose Lima, Marisa B. Marques, Rance C Siniard
532 [GO] Blood 2020―Nov―04 Outcome of Severe Aplastic Anemia Treated with Low Dose Immunosuppression in Resource Limited World during Pandemic: Single Center Experience from Myanmar Aye Aye Gyi, Khin Thida Htut, Yin Nwe Han, Mie Mie Khine, Hnin Mya Thandar, Yi Mon Thant
533 [GO] Blood Advances 2020―Nov―02 Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study Jason B. Hill, David Garcia, Mark Crowther, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig
534 [GO] Blood 2020―Oct―29 Targeting complement activation in COVID-19 Hrishikesh S. Kulkarni, John P. Atkinson
535 [GO] Blood 2020―Oct―28 Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients Abi Vijenthira, Inna Y. Gong, Thomas A Fox, Stephen Booth, Gordon Cook, Bruno Fattizzo, et al. (+13)
536 [GO] Blood 2020―Oct―26 SARS-CoV-2 specific T-cells Are Rapidly Expanded for Therapeutic Use and Target Conserved Regions of Membrane Protein Michael D. Keller, Katherine M. Harris, Mariah A. Jensen-Wachspress, Vaishnavi Kankate, Haili Lang, Christopher Andrew Lazarski, et al. (+27)
537 [GO] Blood Advances 2020―Oct―19 Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19 Mohammed Osman, Rehan M. Faridi, Wendy Sligl, Meer-Taher Shabani-Rad, Poonam Dharmani-Khan, Arabesque Parker, et al. (+5)
538 [GO] Blood Advances 2020―Oct―14 The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 Ryan L. Hoiland, Nicholas A. Fergusson, Anish R. Mitra, Donald E. G. Griesdale, Dana V. Devine, Sophie Stukas, et al. (+8)
539 [GO] Blood Advances 2020―Oct―14 Reduced prevalence of SARS-CoV-2 infection in ABO blood group O Mike Bogetofte Barnkob, Anton Pottegård, Henrik Støvring, Thure Mors Haunstrup, Keld Homburg, Rune Larsen, et al. (+5)
540 [GO] Blood Advances 2020―Oct―08 Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19 Tim Luetkens, Ryan Metcalf, Vicente Planelles, Yue Zheng, Erin T. Larragoite, Emily S. Spivak, et al. (+11)
541 [GO] Blood 2020―Sep―22 Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease Thomas Hueso, Cécile Pouderoux, Hélène Péré, Anne-Lise Beaumont, Laure-Anne Raillon, Florence Ader, et al. (+31)
542 [GO] Blood Advances 2020―Sep―14 Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia Lia Phillips, Jovana Pavisic, Dominder Kaur, N. Valerio Dorrello, Larisa Broglie, Nobuko Hijiya
543 [GO] Blood Advances 2020―Sep―11 COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease Zahidee Rodriguez, Andi L. Shane, Hans Verkerke, Christopher Lough, Matthew G. Zimmerman, Mehul Suthar, et al. (+8)
544 [GO] Blood 2020―Sep―10 Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19 Eugenio D. Hottz, Isaclaudia G. Azevedo-Quintanilha, Lohanna Palhinha, Lívia Teixeira, Ester A. Barreto, Camila R. R. Pão, et al. (+6)
545 [GO] Blood 2020―Sep―10 COVID-19 concerns aggregate around platelets Elisabeth M. Battinelli
546 [GO] Blood Advances 2020―Sep―04 Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic Duncan Purtill, Vicki Antonenas, Paul Chiappini, Daochen Tong, Elizabeth O’Flaherty, Ashish Bajel, et al. (+11)
547 [GO] Blood 2020―Sep―03 A NET-thrombosis axis in COVID-19 Andrés Hidalgo
548 [GO] Blood 2020―Sep―03 When CLL meets COVID-19 Emili Montserrat
549 [GO] The Hematologist 2020―Sep―03 ASH Members Respond to COVID-19 Challenges ASH Staff
550 [GO] The Hematologist 2020―Sep―03 The Challenge We Face: Sickle Cell Disease and the COVID-19 Pandemic Ahmar U. Zaidi
551 [GO] The Hematologist 2020―Sep―03 Convalescent Plasma for COVID-19: An Old Therapy for a Novel Pathogen David T. Teachey, Caroline Diorio
552 [GO] The Hematologist 2020―Sep―03 COVID-19: ASH's Response Draws on the Strength of Our Community Stephanie Lee
553 [GO] The Hematologist 2020―Sep―03 Unmasking the Immunopathological Characteristics of COVID-19: Monocytes Grow With the Flow and Lymphocytes Shelter in Place? Annette S. Kim
554 [GO] The Hematologist 2020―Sep―03 Hematologic Therapies Being Studied for Coronavirus: Capitalizing on Progress Laura C. Michaelis, Kathleen Monahan
555 [GO] Blood 2020―Sep―02 Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition Jia Yu, Xuan Yuan, Hang Chen, Shruti Chaturvedi, Evan M. Braunstein, Robert A. Brodsky
556 [GO] Blood 2020―Sep―01 No evidence of SARS-CoV-2 transfusion-transmission despite RNA detection in blood donors showing symptoms after donation Pierre Cappy, Daniel Candotti, Virginie Sauvage, Quentin Lucas, Laure Boizeau, Johanna Gomez, et al. (+6)
557 [GO] Blood Advances 2020―Aug―25 The management of venous thromboembolism in hospitalized patients with COVID-19 Alex C. Spyropoulos
558 [GO] Blood 2020―Aug―14 Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome Won Sok Lee, Elizabeth Margolskee
559 [GO] Blood 2020―Aug―14 Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient Gregoire Stalder, Lorenzo Alberio
560 [GO] Blood 2020―Aug―07 Post-discharge thrombosis and hemorrhage in patients with COVID-19 Rushad Patell, Thomas Bogue, Anita G Koshy, Poorva Bindal, Mwanasha Merrill, William C Aird, et al. (+2)
561 [GO] Blood 2020―Aug―06 Convalescent plasma to treat COVID-19 Evan M. Bloch
562 [GO] Blood 2020―Aug―06 COVID-19 and the Coombs test Jeanne E. Hendrickson, Christopher A. Tormey
563 [GO] Blood 2020―Aug―03 Post-discharge venous thromboembolism following hospital admission with COVID-19 Lara N Roberts, Martin Brunel Whyte, Loizos Georgiou, Gerard Giron, Julia Czuprynska, Catherine Rea, et al. (+4)
564 [GO] Blood 2020―Jul―23 COVID-19 coagulopathy, thrombosis, and bleeding Noel C. Chan, Jeffrey I. Weitz
565 [GO] Blood 2020―Jul―20 Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience Anthony R. Mato, Lindsey Elizabeth Roeker, Nicole Lamanna, John Allan, Lori Ann Leslie, John M. Pagel, et al. (+56)
566 [GO] Blood Advances 2020―Jul―01 Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) Bruno Fattizzo, Juri Alessandro Giannotta, Wilma Barcellini, Maria Chiara Barbanti, Cristina Bucelli, Ramona Cassin, et al. (+25)
567 [GO] Blood 2020―Jun―29 Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome Elizabeth A Middleton, Xue-Yan He, Frederik Denorme, Robert A. Campbell, David Ng, Steven P. Salvatore, et al. (+18)
568 [GO] Blood Advances 2020―Jun―23 COVID-19 coagulopathy vs disseminated intravascular coagulation Marcel Levi
569 [GO] Blood 2020―Jun―23 Platelet Gene Expression and Function in COVID-19 Patients Bhanu Kanth Manne, Frederik Denorme, Elizabeth A Middleton, Irina Portier, Jesse W Rowley, Chris J. Stubben, et al. (+8)
570 [GO] Blood 2020―Jun―23 Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion Xinyi Xia, Kening Li, Lingxiang Wu, Zhihua Wang, Mengyan Zhu, Bin Huang, et al. (+19)
571 [GO] Blood 2020―Jun―19 Red cell bound antibodies and transfusion requirements in hospitalized patients with COVID-19 Alessandra Berzuini, Cristiana Bianco, Cinzia Paccapelo, Francesco Bertolini, Giuliana Gregato, Alessandra Cattaneo, et al. (+13)
572 [GO] Blood 2020―Jun―19 Use of Convalescent Plasma in Hospitalized Patients with Covid-19 - Case Series Livia Hegerova, Ted Gooley, Kelly A Sweerus, Cynthia L Maree, Neil Bailey, Megumi Bailey, et al. (+14)
573 [GO] Blood Advances 2020―Jun―19 A report of clustered COVID-19 in a hematology ward Yaohui Wu, Fang Liu, Yun Fang, Xuan Lu, Yingying Wu, Linghui Xia, Mei Hong
574 [GO] Blood 2020―Jun―19 CHRONIC LYMPHOCYTIC LEUKEMIA MANAGEMENT IN ITALY DURING THE COVID-19 PANDEMIC. A CAMPUS CLL REPORT Antonio Cuneo, Lydia Scarfo, Gianluigi Reda, Marzia Varettoni, Francesca Maria Quaglia, Monia Marchetti, et al. (+12)
575 [GO] Blood 2020―Jun―18 Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic Robert Sheppard Nickel, Stefanie Margulies, Brittany Frazer, Naomi L. C. Luban, Jennifer Webb
576 [GO] Blood 2020―Jun―18 Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection Klaas Dewaele, Rowan Claeys
577 [GO] Blood 2020―Jun―18 Morphological changes in a case of SARS-CoV-2 infection John R. Jones, Robin Ireland
578 [GO] Blood 2020―Jun―11 Hypersegmented granulocytes and COVID-19 infection Christian Salib, Julie Teruya-Feldstein
579 [GO] Blood 2020―Jun―03 House Calls for Stem Cell Transplants During the COVID-19 Pandemic. Anthony D Sung, Krista R. Nichols, Nelson J. Chao
580 [GO] Blood 2020―Jun―03 COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection Hanny Al-Samkari, Rebecca S Karp Leaf, Walter H Dzik, Jonathan CT Carlson, Annemarie E Fogerty, Anem Waheed, et al. (+7)
581 [GO] Blood 2020―May―28 COVID-19 and SCA: an old friend comes to the rescue Enrico M. Novelli
582 [GO] Blood 2020―May―28 Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study Douglas Tremblay, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina Justine Kessler, Sangeetha Venugopal, et al. (+13)
583 [GO] Blood 2020―May―27 Tocilizumab not associated with increased infection risk after CAR T - Implications for COVID-19? Matthew J Frigault, Sarah Nikiforow, Michael Mansour, Zhen-Huan Hu, Mary M Horowitz, Marcie Riches, et al. (+5)
584 [GO] Blood 2020―Apr―27 COVID-19 and its implications for thrombosis and anticoagulation Jean Marie Connors, Jerrold H Levy
585 [GO] Blood 2020―Apr―17 The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients Steven P Treon, Jorge Castillo, Alan P Skarbnik, Jacob D Soumerai, Irene M Ghobrial, Maria Luisa Guerrera, et al. (+2)
586 [GO] Blood 2020―Apr―13 Initiating adjunct low dose-hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic Michael R DeBaun
587 [GO] Blood 2020―Apr―10 ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic Joachim Yahalom, Bouthaina S. Dabaja, Umberto Ricardi, Andrea Ng, N. George Mikhaeel, Ivan Richter Vogelius, et al. (+4)
588 [GO] Blood Advances 2020―Apr―03 First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab Xuhan Zhang, Kaidi Song, Fei Tong, Mingming Fei, Hui Guo, Zhaohui Lu, et al. (+2)
 [1] 

588 Results       Page 1




[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.253 sec